Signal	B-protein
transducer	I-protein
and	I-protein
activator	I-protein
of	I-protein
transcription-3	I-protein
(	O
STAT3	B-protein
)	O
is	O
constitutively	O
activated	O
in	O
normal	O
,	O
self-renewing	B-cell_type
B-1	I-cell_type
cells	I-cell_type
but	O
only	O
inducibly	O
expressed	O
in	O
conventional	O
B	B-cell_type
lymphocytes	I-cell_type
[	O
see	O
comments	O
]	O

Cytokine	B-protein
and	O
growth	B-protein
factor	I-protein
receptor	I-protein
engagement	O
leads	O
to	O
the	O
rapid	O
phosphorylation	O
and	O
activation	O
of	O
latent	O
,	O
cytosolic	B-protein
signal	I-protein
transducers	I-protein
and	I-protein
activators	I-protein
of	I-protein
transcription	I-protein
(	I-protein
STAT	I-protein
)	I-protein
proteins	I-protein
,	O
which	O
then	O
translocate	O
to	O
the	O
nucleus	O
where	O
they	O
regulate	O
transcriptional	O
events	O
from	O
specific	B-DNA
promoter	I-DNA
sequences	I-DNA
.	O

STAT3	B-protein
expression	O
in	O
particular	O
has	O
been	O
associated	O
with	O
Abl	B-protein
,	O
Src	B-protein
,	O
and	O
HTLV-1	O
transformation	O
of	O
normal	B-cell_type
cells	I-cell_type
.	O

B-1	B-cell_type
lymphocytes	I-cell_type
are	O
self-renewing	O
,	O
CD5+	B-cell_type
B	I-cell_type
cells	I-cell_type
that	O
display	O
a	O
propensity	O
for	O
malignant	O
transformation	O
and	O
are	O
the	O
normal	O
counterpart	O
to	O
human	O
chronic	O
lymphocytic	O
leukemias	O
.	O

Further	O
,	O
B-1	B-cell_type
cells	I-cell_type
are	O
characterized	O
by	O
aberrant	O
intracellular	O
signaling	O
,	O
including	O
hyperresponsiveness	O
to	O
phorbol	O
ester	O
PKC	O
agonists	O
.	O

Here	O
we	O
demonstrate	O
that	O
B-1	B-cell_type
lymphocytes	I-cell_type
constitutively	O
express	O
nuclear	B-protein
activated	I-protein
STAT3	I-protein
,	O
which	O
is	O
not	O
expressed	O
by	O
unmanipulated	B-cell_type
conventional	I-cell_type
(	I-cell_type
B-2	I-cell_type
)	I-cell_type
lymphocytes	I-cell_type
.	O

In	O
contrast	O
,	O
STAT3	B-protein
activation	O
is	O
induced	O
in	O
B-2	B-cell_type
cells	I-cell_type
after	O
antigen	O
receptor	O
engagement	O
in	O
a	O
delayed	O
fashion	O
(	O
after	O
3	O
h	O
)	O
.	O

Induction	O
of	O
STAT3	B-protein
is	O
inhibited	O
by	O
both	O
the	O
serine/threonine	O
protein	O
kinase	O
inhibitor	O
H-7	O
and	O
the	O
immunosuppressive	O
drug	O
rapamycin	O
and	O
requires	O
de	O
novo	O
protein	O
synthesis	O
,	O
demonstrating	O
novel	O
coupling	O
between	O
sIg	B-protein
and	O
STAT	B-protein
proteins	I-protein
that	O
differs	O
from	O
the	O
classical	O
paradigm	O
for	O
STAT	B-protein
induction	O
by	O
cytokine	B-protein
receptors	I-protein
.	O

The	O
inability	O
of	O
prolonged	O
stimulation	O
of	O
conventional	O
B-2	B-cell_type
cells	I-cell_type
with	O
anti-Ig	B-protein
,	O
a	O
treatment	O
sufficient	O
to	O
induce	O
CD5	B-protein
expression	O
,	O
to	O
result	O
in	O
sustained	O
STAT3	B-protein
activation	O
suggests	O
that	O
STAT3	B-protein
is	O
a	O
specific	O
nuclear	O
marker	O
for	O
B-1	B-cell_type
cells	I-cell_type
.	O

Thus	O
,	O
STAT3	B-protein
may	O
play	O
a	O
role	O
in	O
B	O
cell	O
antigen-specific	O
signaling	O
responses	O
,	O
and	O
its	O
constitutive	O
activation	O
is	O
associated	O
with	O
a	O
normal	O
cell	O
population	O
exhibiting	O
intrinsic	O
proliferative	O
behavior	O
.	O

Signal	NULL
Transducer	NULL
and	NULL
Activator	NULL
of	NULL
Transcription-3	NULL
(	NULL
STAT3	NULL
)	NULL
Is	NULL
Constitutively	NULL
Activated	NULL
in	NULL
Normal	NULL
,	NULL
Self-renew	NULL
ing	NULL
B-1	NULL
Cells	NULL
but	NULL
Only	NULL
Inducibly	NULL
Expressed	NULL
in	NULL
Conventional	NULL
B	NULL
Lymphocytes	NULL
By	NULL
James	NULL
G.	NULL
Karras	NULL
,	NULL
*	NULL
Zihua	NULL
Wang	NULL
,	NULL
*	NULL
Li	NULL
Huo	NULL
,	NULL
*	NULL
Robert	NULL
G.	NULL
Howard	NULL
,	NULL
*	NULL
David	NULL
A.	NULL
Frank	NULL
,	NULL
$	NULL
and	NULL
Thomas	NULL
L.	NULL
R	NULL
othstein	NULL
**	NULL
From	NULL
the	NULL
*Department	NULL
of	NULL
Mediane	NULL
and	NULL
the	NULL
*Department	NULL
of	NULL
Micbiology	NULL
and	NULL
the	NULL
Evans	NULL
Memorial	NULL
Department	NULL
of	NULL
Clinial	NULL
Research	NULL
,	NULL
Boston	NULL
University	NULL
Medial	NULL
Center	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02118	NULL
;	NULL
and	NULL
$	NULL
Division	NULL
of	NULL
Hematological	NULL
Malignandes	NULL
Dana-Farber	NULL
C	NULL
ancer	NULL
Institute	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
Sum	NULL
m	NULL
ary	NULL
Cytokine	NULL
and	NULL
growth	NULL
factor	NULL
receptor	NULL
engagement	NULL
leads	NULL
to	NULL
the	NULL
rapid	NULL
phosphorylation	NULL
and	NULL
activation	NULL
of	NULL
latent	NULL
,	NULL
cytosolic	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
proteins	NULL
,	NULL
which	NULL
then	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
where	NULL
they	NULL
regulate	NULL
transcriptional	NULL
events	NULL
from	NULL
specific	NULL
promoter	NULL
sequences	NULL
.	NULL

STAT3	NULL
expression	NULL
in	NULL
particular	NULL
has	NULL
been	NULL
associated	NULL
with	NULL
Abl	NULL
,	NULL
Src	NULL
,	NULL
and	NULL
HTLV-1	NULL
transformation	NULL
of	NULL
normal	NULL
cells	NULL
.	NULL

B-	NULL
1	NULL
lymphocytes	NULL
are	NULL
self-renewing	NULL
,	NULL
CD5	NULL
*	NULL
B	NULL
cells	NULL
that	NULL
display	NULL
a	NULL
propensity	NULL
for	NULL
malignant	NULL
transformation	NULL
and	NULL
are	NULL
the	NULL
normal	NULL
counterpart	NULL
to	NULL
human	NULL
chronic	NULL
lymphocytic	NULL
leukemias	NULL
.	NULL

Further	NULL
,	NULL
B-1	NULL
cells	NULL
are	NULL
characterized	NULL
by	NULL
aberrant	NULL
intracellular	NULL
signaling	NULL
,	NULL
including	NULL
hyperresponsiveness	NULL
to	NULL
phorbol	NULL
ester	NULL
PKC	NULL
agonists	NULL
.	NULL

Here	NULL
we	NULL
demonstrate	NULL
that	NULL
B-	NULL
1	NULL
lymphocytes	NULL
constitutively	NULL
express	NULL
nuclear	NULL
activated	NULL
STAT	NULL
3	NULL
,	NULL
which	NULL
is	NULL
not	NULL
expressed	NULL
by	NULL
unmanipulated	NULL
conventional	NULL
(	NULL
B-2	NULL
)	NULL
lymphocytes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
STAT	NULL
3	NULL
activation	NULL
is	NULL
induced	NULL
in	NULL
B-2	NULL
cells	NULL
after	NULL
antigen	NULL
receptor	NULL
engagement	NULL
in	NULL
a	NULL
delayed	NULL
fashion	NULL
(	NULL
after	NULL
3	NULL
h	NULL
)	NULL
.	NULL

Induction	NULL
of	NULL
STAT3	NULL
is	NULL
inhibited	NULL
by	NULL
both	NULL
the	NULL
serine/	NULL
threonine	NULL
protein	NULL
kinase	NULL
inhibitor	NULL
H-7	NULL
and	NULL
the	NULL
immunosuppressive	NULL
drug	NULL
rapamycin	NULL
and	NULL
requires	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
,	NULL
demonstrating	NULL
novel	NULL
coupling	NULL
between	NULL
slg	NULL
and	NULL
STAT	NULL
proteins	NULL
that	NULL
differs	NULL
from	NULL
the	NULL
classical	NULL
paradigm	NULL
for	NULL
STAT	NULL
induction	NULL
by	NULL
cytokine	NULL
receptors	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
prolonged	NULL
stimulation	NULL
of	NULL
conventional	NULL
B-2	NULL
cells	NULL
with	NULL
anti-Ig	NULL
,	NULL
a	NULL
treatment	NULL
sufficient	NULL
to	NULL
induce	NULL
CD5	NULL
expression	NULL
,	NULL
to	NULL
result	NULL
in	NULL
sustained	NULL
STAT	NULL
3	NULL
activation	NULL
suggests	NULL
that	NULL
STAT	NULL
3	NULL
is	NULL
a	NULL
specific	NULL
nuclear	NULL
marker	NULL
for	NULL
B-1	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
STAT	NULL
3	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
B	NULL
cell	NULL
antigen-specific	NULL
signaling	NULL
responses	NULL
,	NULL
and	NULL
its	NULL
constitutive	NULL
activation	NULL
is	NULL
associated	NULL
with	NULL
a	NULL
normal	NULL
cell	NULL
population	NULL
exhibiting	NULL
intrinsic	NULL
proliferative	NULL
behavior	NULL
.	NULL

he	NULL
67-kD	NULL
pan-T	NULL
cell	NULL
surface	NULL
glycoprotein	NULL
,	NULL
CD5	NULL
,	NULL
was	NULL
first	NULL
detected	NULL
on	NULL
the	NULL
surface	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
B	NULL
cell	NULL
tumors	NULL
and	NULL
subsequently	NULL
found	NULL
to	NULL
specify	NULL
a	NULL
subset	NULL
of	NULL
normal	NULL
B	NULL
lymphocytes	NULL
in	NULL
both	NULL
species	NULL
(	NULL
1	NULL
)	NULL
.	NULL

CD5¢*	NULL
(	NULL
or	NULL
B-1	NULL
)	NULL
B	NULL
lymphocytes	NULL
are	NULL
mature	NULL
B	NULL
cells	NULL
that	NULL
predominate	NULL
early	NULL
in	NULL
life	NULL
,	NULL
decline	NULL
in	NULL
relative	NULL
number	NULL
as	NULL
the	NULL
animal	NULL
matures	NULL
,	NULL
and	NULL
,	NULL
in	NULL
mice	NULL
,	NULL
become	NULL
confined	NULL
to	NULL
the	NULL
peritoneal	NULL
cavity	NULL
,	NULL
with	NULL
few	NULL
,	NULL
if	NULL
any	NULL
,	NULL
present	NULL
in	NULL
the	NULL
peripheral	NULL
lymph	NULL
nodes	NULL
(	NULL
2	NULL
)	NULL
.	NULL

Functionally	NULL
,	NULL
B-1	NULL
cells	NULL
contribute	NULL
a	NULL
disproportionally	NULL
large	NULL
fraction	NULL
of	NULL
serum	NULL
Ig	NULL
,	NULL
specifically	NULL
of	NULL
the	NULL
pw	NULL
,	NULL
«	NULL
,	NULL
and	NULL
y	NULL
classes	NULL
.	NULL

These	NULL
Igs	NULL
are	NULL
noted	NULL
to	NULL
express	NULL
germline	NULL
encoded	NULL
specifici-ties	NULL
,	NULL
with	NULL
little	NULL
somatic	NULL
mutation	NULL
and	NULL
N-insertion	NULL
and	NULL
may	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
idiotype	NULL
expression	NULL
(	NULL
3	NULL
,	NULL
4	NULL
)	NULL
.	NULL

B-	NULL
1	NULL
cells	NULL
have	NULL
been	NULL
linked	NULL
to	NULL
both	NULL
autoantibody	NULL
production	NULL
and	NULL
the	NULL
pathogenesis	NULL
of	NULL
autoimmune	NULL
disease	NULL
as	NULL
well	NULL
as	NULL
malignancy	NULL
(	NULL
2	NULL
,	NULL
5	NULL
)	NULL
.	NULL

CD5	NULL
*	NULL
B	NULL
cells	NULL
have	NULL
been	NULL
found	NULL
to	NULL
be	NULL
enriched	NULL
sources	NULL
of	NULL
autoantibody-producing	NULL
cells	NULL
specific	NULL
for	NULL
various	NULL
self-antigens	NULL
,	NULL
and	NULL
several	NULL
mouse	NULL
strains	NULL
that	NULL
develop	NULL
1035	NULL
autoimmune	NULL
pathology	NULL
have	NULL
elevated	NULL
numbers	NULL
of	NULL
splenic	NULL
and	NULL
peritoneal	NULL
CD5	NULL
B	NULL
cells	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Adoptive	NULL
transfer	NULL
experiments	NULL
have	NULL
demonstrated	NULL
that	NULL
B-	NULL
1	NULL
cells	NULL
have	NULL
self-renewing	NULL
capacity	NULL
(	NULL
8	NULL
)	NULL
,	NULL
and	NULL
in	NULL
vitro	NULL
,	NULL
these	NULL
cells	NULL
are	NULL
readily	NULL
immortalized	NULL
in	NULL
culture	NULL
without	NULL
the	NULL
use	NULL
of	NULL
exogenously	NULL
induced	NULL
transformation	NULL
(	NULL
9	NULL
)	NULL
.	NULL

Coupled	NULL
with	NULL
their	NULL
hyperresponsiveness	NULL
to	NULL
PMA	NULL
stimulation	NULL
and	NULL
their	NULL
inability	NULL
to	NULL
enter	NULL
S	NULL
phase	NULL
after	NULL
slg	NULL
cross-linking	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
these	NULL
observations	NULL
suggest	NULL
that	NULL
B-	NULL
1	NULL
cells	NULL
differ	NULL
from	NULL
B-2	NULL
cells	NULL
in	NULL
their	NULL
biochemical	NULL
makeup	NULL
in	NULL
ways	NULL
that	NULL
may	NULL
contribute	NULL
to	NULL
autoantibody	NULL
secretion	NULL
and	NULL
unregulated	NULL
growth	NULL
.	NULL

Signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
(	NULL
STAT	NULL
)	NULL
!	NULL

proteins	NULL
were	NULL
first	NULL
characterized	NULL
by	NULL
studying	NULL
signaling	NULL
in	NULL
re	NULL
!	NULL

A	NULL
bbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
CHX	NULL
,	NULL
cycloheximide	NULL
;	NULL
CNTF	NULL
,	NULL
ciliary	NULL
neurotrophic	NULL
factor	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
SIE	NULL
,	NULL
inducible	NULL
element	NULL
;	NULL
SIF	NULL
,	NULL
sis-inducible	NULL
factor	NULL
;	NULL
ST	NULL
AT	NULL
,	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
;	NULL
TI-2	NULL
,	NULL
T	NULL
cell-indepen-dent	NULL
type	NULL
II	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

©	NULL
The	NULL
R	NULL
ockefeller	NULL
University	NULL
Press	NULL
»	NULL
0022-1007/97/03/	NULL
1035/08	NULL
$	NULL
2.00	NULL
Volume	NULL
185	NULL
,	NULL
Number	NULL
6	NULL
,	NULL
March	NULL
17	NULL
,	NULL
1997	NULL
1035-1042	NULL
sponse	NULL
to	NULL
interferon	NULL
and	NULL
have	NULL
since	NULL
been	NULL
implicated	NULL
in	NULL
cellular	NULL
responses	NULL
to	NULL
a	NULL
plethora	NULL
of	NULL
cytokines	NULL
and	NULL
growth	NULL
factors	NULL
(	NULL
12	NULL
,	NULL
13	NULL
)	NULL
.	NULL

STAT	NULL
signaling	NULL
involves	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
JAK/	NULL
tyk	NULL
family	NULL
of	NULL
tyrosine	NULL
kinases	NULL
that	NULL
are	NULL
believed	NULL
to	NULL
be	NULL
associated	NULL
with	NULL
unliganded	NULL
cytokine	NULL
receptors	NULL
and	NULL
to	NULL
phos-phorylate	NULL
latent	NULL
cytoplasmic	NULL
STAT	NULL
proteins	NULL
upon	NULL
ligand	NULL
binding	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Phosphorylated	NULL
ST	NULL
AT	NULL
's	NULL
dimerize	NULL
via	NULL
interactions	NULL
between	NULL
their	NULL
SH2	NULL
domains	NULL
(	NULL
15	NULL
)	NULL
,	NULL
allowing	NULL
nuclear	NULL
translocation	NULL
and	NULL
DN	NULL
A	NULL
binding	NULL
activity	NULL
specific	NULL
for	NULL
distinct	NULL
sequence	NULL
elements	NULL
in	NULL
cytokine	NULL
and	NULL
growth	NULL
factor-stimu-lated	NULL
genes	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
mitogenic	NULL
stimulation	NULL
through	NULL
surface	NULL
Ig	NULL
in	NULL
B-2	NULL
cells	NULL
induces	NULL
the	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
(	NULL
16	NULL
)	NULL
.	NULL

This	NULL
observation	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
association	NULL
of	NULL
STAT	NULL
3	NULL
with	NULL
abnormal	NULL
cell	NULL
growth	NULL
and	NULL
transformation	NULL
(	NULL
17-20	NULL
)	NULL
,	NULL
led	NULL
us	NULL
to	NULL
compare	NULL
the	NULL
status	NULL
and	NULL
activational	NULL
responses	NULL
of	NULL
STAT3	NULL
proteins	NULL
in	NULL
B-1	NULL
and	NULL
B-2	NULL
cells	NULL
.	NULL

O	NULL
ur	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
nuclear	NULL
expression	NULL
of	NULL
activated	NULL
STAT	NULL
proteins	NULL
differs	NULL
between	NULL
B-1	NULL
and	NULL
B-2	NULL
cells	NULL
and	NULL
that	NULL
the	NULL
STAT	NULL
protein	NULL
profile	NULL
may	NULL
be	NULL
a	NULL
distinguishing	NULL
molecular	NULL
feature	NULL
of	NULL
the	NULL
B-	NULL
1	NULL
cell	NULL
phenotype	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Animals	NULL
.	NULL

-	NULL
Male	NULL
BALB/	NULL
cByJ	NULL
mice	NULL
at	NULL
8-14	NULL
wk	NULL
of	NULL
age	NULL
were	NULL
obtained	NULL
from	NULL
The	NULL
Jackson	NULL
Laboratory	NULL
(	NULL
Bar	NULL
Harbor	NULL
,	NULL
ME	NULL
)	NULL
.	NULL

Mice	NULL
were	NULL
housed	NULL
at	NULL
least	NULL
1	NULL
wk	NULL
before	NULL
experimentation	NULL
.	NULL

Mice	NULL
were	NULL
cared	NULL
for	NULL
and	NULL
handled	NULL
at	NULL
all	NULL
times	NULL
in	NULL
accordance	NULL
with	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
and	NULL
institutional	NULL
guidelines	NULL
.	NULL

B	NULL
Cell	NULL
Purification	NULL
.	NULL

B-1	NULL
lymphocytes	NULL
were	NULL
prepared	NULL
by	NULL
negative	NULL
selection	NULL
from	NULL
peritoneal	NULL
wash-out	NULL
cells	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
21	NULL
)	NULL
.	NULL

B-2	NULL
cells	NULL
were	NULL
purified	NULL
from	NULL
spleen	NULL
cells	NULL
of	NULL
8-12-wk-old	NULL
naive	NULL
mice	NULL
by	NULL
depletion	NULL
of	NULL
T	NULL
cells	NULL
using	NULL
treatment	NULL
with	NULL
anti-Thy	NULL
1.2	NULL
antibody	NULL
plus	NULL
rabbit	NULL
complement	NULL
and	NULL
depletion	NULL
of	NULL
macrophages	NULL
by	NULL
overnight	NULL
culture	NULL
on	NULL
plastic	NULL
petri	NULL
dishes	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
22	NULL
)	NULL
.	NULL

RBC	NULL
and	NULL
nonviable	NULL
cells	NULL
were	NULL
removed	NULL
by	NULL
sedimentation	NULL
over	NULL
Lympholyte	NULL
M	NULL
(	NULL
Cedarlane	NULL
,	NULL
Ontario	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL

The	NULL
resulting	NULL
B	NULL
cells	NULL
were	NULL
cultured	NULL
at	NULL
37°C	NULL
with	NULL
5	NULL
%	NULL
CO	NULL
;	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
BioWhittaker	NULL
,	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
heat	NULL
inactivated	NULL
fetal	NULL
bovine	NULL
serum	NULL
(	NULL
Sigma	NULL
Chem	NULL
.	NULL

Co.	NULL
,	NULL
St.	NULL
Louis	NULL
MO	NULL
)	NULL
,	NULL
10	NULL
mM	NULL
Hepes	NULL
(	NULL
pH	NULL
7.2	NULL
)	NULL
,	NULL
50	NULL
wM	NULL
2-ME	NULL
,	NULL
2	NULL
mM	NULL
1-glutamine	NULL
,	NULL
100	NULL
U/ml	NULL
penicillin	NULL
,	NULL
and	NULL
100	NULL
jwg/	NULL
ml	NULL
streptomycin	NULL
.	NULL

In	NULL
some	NULL
experiments	NULL
,	NULL
B-	NULL
1	NULL
cells	NULL
were	NULL
prepared	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
serum-free	NULL
RPMI	NULL
1640	NULL
medium	NULL
containing	NULL
1	NULL
%	NULL
bovine	NULL
serum	NULL
albumin	NULL
and	NULL
cultured	NULL
in	NULL
serum-free	NULL
AIM-V	NULL
medium	NULL
(	NULL
GIBCO	NULL
BRL	NULL
,	NULL
Gaithersburg	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

Nudear	NULL
Extrads	NULL
and	NULL
Eledrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay	NULL
.	NULL

_	NULL
Nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
or	NULL
stimulated	NULL
primary	NULL
B	NULL
cells	NULL
were	NULL
prepared	NULL
using	NULL
430	NULL
mM	NULL
NaCl	NULL
at	NULL
pH	NULL
7.9	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
22	NULL
)	NULL
,	NULL
except	NULL
that	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
was	NULL
added	NULL
to	NULL
all	NULL
extraction	NULL
buffers	NULL
.	NULL

Protein	NULL
concentrations	NULL
were	NULL
determined	NULL
by	NULL
the	NULL
Bradford	NULL
method	NULL
(	NULL
23	NULL
)	NULL
(	NULL
Bio-R	NULL
ad	NULL
,	NULL
Hercules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Nuclear	NULL
extracted	NULL
protein	NULL
was	NULL
incubated	NULL
with	NULL
P-labeled	NULL
double-stranded	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
high-affinity	NULL
SIE	NULL
(	NULL
m67	NULL
)	NULL
derived	NULL
from	NULL
the	NULL
c-fos	NULL
gene	NULL
(	NULL
24	NULL
)	NULL
for	NULL
20	NULL
min	NULL
before	NULL
electrophoresis	NULL
on	NULL
nondenaturing	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Binding	NULL
reactions	NULL
contained	NULL
1	NULL
jug	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
and	NULL
2.0	NULL
ug	NULL
salmon	NULL
sperm	NULL
DN	NULL
A	NULL
.	NULL

For	NULL
competition	NULL
analysis	NULL
,	NULL
20-fold	NULL
excess	NULL
unlabeled	NULL
SIE	NULL
or	NULL
NF-AT	NULL
oligonucleotide	NULL
(	NULL
25	NULL
)	NULL
was	NULL
added	NULL
to	NULL
binding	NULL
reactions	NULL
before	NULL
addition	NULL
of	NULL
nuclear	NULL
protein	NULL
and	NULL
electro-phoresis	NULL
.	NULL

Supershift/	NULL
immunoinhibition	NULL
analysis	NULL
was	NULL
performed	NULL
by	NULL
addition	NULL
of	NULL
1	NULL
pl	NULL
anti-p91N	NULL
or	NULL
antiphosphotyrosine	NULL
``	NULL
``	NULL
STAT1	NULL
for	NULL
1036	NULL
an	NULL
additional	NULL
30	NULL
min	NULL
at	NULL
4°C	NULL
after	NULL
the	NULL
20-min	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
EMSA	NULL
)	NULL
binding	NULL
reaction	NULL
.	NULL

Westem	NULL
Blotting	NULL
.	NULL

Nuclear	NULL
extracted	NULL
protein	NULL
(	NULL
5	NULL
jug	NULL
)	NULL
was	NULL
resolved	NULL
by	NULL
7.5	NULL
%	NULL
SDS-PAGE	NULL
,	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
nonfat	NULL
powdered	NULL
milk	NULL
in	NULL
wash	NULL
buffer	NULL
(	NULL
20	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.6	NULL
,	NULL
0.14	NULL
M	NULL
NaCl	NULL
,	NULL
and	NULL
0.1	NULL
%	NULL
Tween-20	NULL
;	NULL
TBS-T	NULL
)	NULL
overnight	NULL
at	NULL
4°C	NULL
.	NULL

The	NULL
nitrocellulose	NULL
filters	NULL
were	NULL
then	NULL
probed	NULL
with	NULL
antiphos	NULL
photyrosine	NULL
``	NULL
``	NULL
STAT	NULL
1	NULL
(	NULL
26	NULL
)	NULL
,	NULL
or	NULL
with	NULL
antiphosphotyrosine	NULL
``	NULL
``	NULL
``	NULL
STAT	NULL
3	NULL
antiserum	NULL
,	NULL
generated	NULL
by	NULL
immunization	NULL
of	NULL
rabbits	NULL
with	NULL
a	NULL
synthetic	NULL
peptide	NULL
containing	NULL
amino	NULL
acids	NULL
696-709	NULL
of	NULL
human	NULL
STAT3	NULL
,	NULL
with	NULL
phosphotyrosine	NULL
at	NULL
position	NULL
705	NULL
,	NULL
which	NULL
was	NULL
conjugated	NULL
to	NULL
bovine	NULL
serum	NULL
albumin	NULL
.	NULL

Blots	NULL
were	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
with	NULL
antibody	NULL
in	NULL
3	NULL
%	NULL
BSA-TBS-T.	NULL
After	NULL
washing	NULL
,	NULL
blots	NULL
were	NULL
developed	NULL
by	NULL
ECL	NULL
.	NULL

Shift-W	NULL
estem	NULL
.	NULL

-	NULL
EMSA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
except	NULL
5	NULL
jug	NULL
of	NULL
nuclear	NULL
extracts	NULL
were	NULL
added	NULL
to	NULL
1.5	NULL
%	NULL
the	NULL
normal	NULL
amount	NULL
of	NULL
labeled	NULL
oligonucleotide	NULL
and	NULL
electrophoresed	NULL
on	NULL
5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

SIE-binding	NULL
proteins	NULL
were	NULL
separated	NULL
from	NULL
retarded	NULL
labeled	NULL
oligonucleotide	NULL
by	NULL
electrophoretic	NULL
transfer	NULL
from	NULL
the	NULL
native	NULL
gel	NULL
to	NULL
nitrocellulose	NULL
paper	NULL
.	NULL

Labeled	NULL
oligonucleotide	NULL
was	NULL
detected	NULL
bound	NULL
to	NULL
DE-81	NULL
paper	NULL
(	NULL
Whatman	NULL
,	NULL
Hillsboro	NULL
,	NULL
OR	NULL
)	NULL
placed	NULL
under	NULL
the	NULL
nitrocellulose	NULL
filter	NULL
and	NULL
on	NULL
top	NULL
of	NULL
Whatman	NULL
filter	NULL
paper	NULL
.	NULL

After	NULL
transfer	NULL
,	NULL
the	NULL
nitrocellulose	NULL
filters	NULL
were	NULL
blocked	NULL
and	NULL
Western	NULL
blotted	NULL
as	NULL
above	NULL
and	NULL
the	NULL
DE-81/	NULL
Whatman	NULL
filters	NULL
were	NULL
dried	NULL
for	NULL
10	NULL
min	NULL
before	NULL
autoradiography	NULL
.	NULL

Reagents	NULL
.	NULL

-	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragments	NULL
of	NULL
goat	NULL
anti-mouse	NULL
IgM	NULL
(	NULL
Jackson	NULL
Immunoresearch	NULL
,	NULL
Inc.	NULL
,	NULL
West	NULL
Grove	NULL
,	NULL
PA	NULL
)	NULL
were	NULL
used	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
15	NULL
g/ml	NULL
.	NULL

PMA	NULL
(	NULL
Sigma	NULL
)	NULL
was	NULL
used	NULL
at	NULL
100	NULL
ng/ml	NULL
.	NULL

Cells	NULL
were	NULL
stimulated	NULL
with	NULL
murine	NULL
recombinant	NULL
IFN-y	NULL
(	NULL
5	NULL
ng/ml	NULL
)	NULL
or	NULL
IL-6	NULL
(	NULL
1,000	NULL
U/	NULL
ml	NULL
)	NULL
,	NULL
both	NULL
from	NULL
Genzyme	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

R	NULL
ab-bit	NULL
antiserum	NULL
to	NULL
the	NULL
NH	NULL
,	NULL
-terminal	NULL
domain	NULL
of	NULL
p91	NULL
(	NULL
anti-p91N	NULL
)	NULL
was	NULL
the	NULL
kind	NULL
gift	NULL
of	NULL
Dr.	NULL
C.	NULL
Schindler	NULL
(	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
)	NULL
.	NULL

Rabbit	NULL
antiserum	NULL
specific	NULL
for	NULL
only	NULL
the	NULL
tyrosine-phosphorylated	NULL
form	NULL
of	NULL
STAT	NULL
1	NULL
was	NULL
generated	NULL
by	NULL
immunization	NULL
of	NULL
rabbits	NULL
with	NULL
a	NULL
peptide	NULL
designed	NULL
from	NULL
the	NULL
STAT	NULL
1a	NULL
protein	NULL
containing	NULL
phosphorylated	NULL
Tyr	NULL
701	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Rapamycin	NULL
was	NULL
used	NULL
at	NULL
20	NULL
ng/	NULL
ml	NULL
,	NULL
dissolved	NULL
in	NULL
ethanol	NULL
and	NULL
1-	NULL
(	NULL
5-isoquinolinesulfonyl	NULL
)	NULL
-2-methylpiper-azine	NULL
(	NULL
H-7	NULL
)	NULL
and	NULL
N-	NULL
(	NULL
2'-guanidinoethyl	NULL
)	NULL
-5-isoquinolinesulfonamide	NULL
(	NULL
HA-1004	NULL
)	NULL
(	NULL
LC	NULL
Laboratories	NULL
,	NULL
Woburn	NULL
,	NULL
MA	NULL
)	NULL
were	NULL
used	NULL
at	NULL
25	NULL
M.	NULL
Results	NULL
and	NULL
Discussion	NULL
To	NULL
determine	NULL
whether	NULL
the	NULL
unusual	NULL
growth	NULL
characteristics	NULL
of	NULL
B-	NULL
1	NULL
cells	NULL
are	NULL
accompanied	NULL
by	NULL
differences	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
STAT	NULL
proteins	NULL
,	NULL
we	NULL
compared	NULL
STAT	NULL
DNA-binding	NULL
activities	NULL
between	NULL
resting	NULL
B-1	NULL
and	NULL
B-2	NULL
cells	NULL
Nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
B-	NULL
1	NULL
cells	NULL
formed	NULL
protein-DNA	NULL
complexes	NULL
with	NULL
the	NULL
high-affinity	NULL
sis	NULL
inducible	NULL
element	NULL
(	NULL
SIE	NULL
)	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
(	NULL
27	NULL
)	NULL
,	NULL
a	NULL
recognized	NULL
ST	NULL
AT	NULL
-binding	NULL
site	NULL
(	NULL
1	NULL
)	NULL
,	NULL
as	NULL
detected	NULL
by	NULL
EMSA	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

The	NULL
major	NULL
B-	NULL
1	NULL
cell-specific	NULL
SIE-binding	NULL
activity	NULL
was	NULL
observed	NULL
to	NULL
co-migrate	NULL
with	NULL
the	NULL
IL-6-stimulated	NULL
sis-	NULL
inducible	NULL
factor	NULL
(	NULL
SIF	NULL
)	NULL
A	NULL
binding	NULL
com-plex	NULL
,	NULL
with	NULL
a	NULL
smaller	NULL
amount	NULL
co-migrating	NULL
similarly	NULL
to	NULL
the	NULL
IFN	NULL
SIF	NULL
C	NULL
complex	NULL
(	NULL
24	NULL
,	NULL
28-30	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
SIF	NULL
A	NULL
,	NULL
and	NULL
little	NULL
SIF	NULL
C	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
nuclear	NULL
extracts	NULL
obtained	NULL
from	NULL
unmanipulated	NULL
B-2	NULL
cells	NULL
.	NULL

The	NULL
B-1	NULL
cell	NULL
complexes	NULL
were	NULL
competed	NULL
by	NULL
unlabeled	NULL
SIE-containing	NULL
oligonucleotide	NULL
but	NULL
not	NULL
by	NULL
the	NULL
consensus	NULL
binding	NULL
site	NULL
for	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
B	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
these	NULL
complexes	NULL
are	NULL
specific	NULL
for	NULL
the	NULL
SIE	NULL
.	NULL

The	NULL
constitutive	NULL
expression	NULL
of	NULL
SIF	NULL
complexes	NULL
in	NULL
Activated	NULL
STAT3	NULL
in	NULL
B-1	NULL
Cells	NULL
Comp	NULL
.	NULL

A	NULL
<	NULL
B2	NULL
B1	NULL
-	NULL
B2	NULL
B-2	NULL
§	NULL
%	NULL
IL-6	NULL
y	NULL
&	NULL
he	NULL
-a-	NULL
SIF	NULL
A	NULL
a	NULL
a	NULL
P	NULL
-+-	NULL
SIF	NULL
B	NULL
e	NULL
boil	NULL
-+	NULL
SIF	NULL
C	NULL
-	NULL
<	NULL
C	NULL
B-1B-2	NULL
B-1	NULL
B-1	NULL
M	NULL
#	NULL
4	NULL
B-	NULL
1	NULL
cells	NULL
was	NULL
not	NULL
the	NULL
result	NULL
of	NULL
serum	NULL
induction	NULL
in	NULL
vitro	NULL
,	NULL
as	NULL
these	NULL
complexes	NULL
were	NULL
still	NULL
formed	NULL
from	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
B-1	NULL
cells	NULL
purified	NULL
and	NULL
cultured	NULL
in	NULL
serum-free	NULL
medium	NULL
and	NULL
were	NULL
not	NULL
inducible	NULL
upon	NULL
subsequent	NULL
serum	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
C	NULL
)	NULL
.	NULL

Antibody	NULL
to	NULL
the	NULL
NH	NULL
region	NULL
of	NULL
STAT	NULL
1a	NULL
(	NULL
anti-p91N	NULL
)	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
recognize	NULL
STAT3	NULL
induced	NULL
by	NULL
ciliary	NULL
neurotrophic	NULL
factor	NULL
(	NULL
CNTF	NULL
)	NULL
(	NULL
31	NULL
)	NULL
,	NULL
disrupted	NULL
SIF	NULL
A	NULL
induced	NULL
by	NULL
IL-6	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
.	NULL

The	NULL
constitutively	NULL
expressed	NULL
B-1	NULL
SIF	NULL
A-like	NULL
complex	NULL
was	NULL
also	NULL
disrupted	NULL
by	NULL
anti-pI1N	NULL
but	NULL
not	NULL
by	NULL
an	NULL
antibody	NULL
to	NULL
phosphotyrosine	NULL
``	NULL
``	NULL
``	NULL
ST	NULL
AT	NULL
1	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
A	NULL
)	NULL
.	NULL

Anti-p91N	NULL
formed	NULL
supershifted	NULL
complexes	NULL
with	NULL
SIF	NULL
A	NULL
in	NULL
both	NULL
IL-6-stimulated	NULL
B	NULL
cells	NULL
and	NULL
untreated	NULL
B-1	NULL
cells	NULL
which	NULL
were	NULL
apparent	NULL
in	NULL
longer	NULL
exposures	NULL
and	NULL
showed	NULL
identical	NULL
electrophoretic	NULL
mobilities	NULL
;	NULL
anti-sera	NULL
to	NULL
STAT	NULL
4	NULL
,	NULL
5	NULL
,	NULL
or	NULL
6	NULL
failed	NULL
to	NULL
react	NULL
with	NULL
the	NULL
B-	NULL
1	NULL
cell	NULL
SIF	NULL
A	NULL
complex	NULL
in	NULL
EMSA	NULL
supershift	NULL
assays	NULL
or	NULL
with	NULL
B-1	NULL
cell	NULL
nuclear	NULL
extracts	NULL
in	NULL
Western	NULL
blotting	NULL
experiments	NULL
,	NULL
and	NULL
antibody	NULL
that	NULL
supershifted	NULL
STAT1	NULL
activated	NULL
by	NULL
IFN-y	NULL
immunoin-hibited/	NULL
supershifted	NULL
only	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
the	NULL
SIF	NULL
C	NULL
complex	NULL
of	NULL
B-1	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Because	NULL
ST	NULL
AT3	NULL
is	NULL
only	NULL
known	NULL
to	NULL
form	NULL
homodimers	NULL
or	NULL
to	NULL
heterodimerize	NULL
with	NULL
STAT	NULL
1	NULL
,	NULL
these	NULL
results	NULL
strongly	NULL
suggest	NULL
that	NULL
B-1	NULL
cells	NULL
differ	NULL
from	NULL
B-2	NULL
cells	NULL
in	NULL
the	NULL
basal	NULL
nuclear	NULL
expression	NULL
of	NULL
STAT3	NULL
homodimers	NULL
that	NULL
comprise	NULL
the	NULL
SIF	NULL
A	NULL
nucleoprotein	NULL
complex	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
contribution	NULL
of	NULL
phosphorylated	NULL
STAT3	NULL
to	NULL
the	NULL
SIF	NULL
A	NULL
complex	NULL
constitutively	NULL
present	NULL
in	NULL
B-1	NULL
cells	NULL
,	NULL
we	NULL
performed	NULL
Shift-Western	NULL
experiments	NULL
,	NULL
using	NULL
nuclear	NULL
extracted	NULL
protein	NULL
,	NULL
the	NULL
SIE-containing	NULL
oligonucleotide	NULL
,	NULL
and	NULL
anti	NULL
1037	NULL
Karras	NULL
et	NULL
al	NULL
.	NULL

a	NULL
Figure	NULL
1	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
specific	NULL
nuclear	NULL
SIE-binding	NULL
activity	NULL
that	NULL
co-migrates	NULL
with	NULL
IL-6-induced	NULL
SIF	NULL
A	NULL
in	NULL
B-1	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
B-2	NULL
cells	NULL
(	NULL
15	NULL
X	NULL
10°	NULL
)	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
treated	NULL
with	NULL
IL-6	NULL
(	NULL
1,000	NULL
U/	NULL
ml	NULL
for	NULL
15	NULL
min	NULL
;	NULL
Genzyme	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
or	NULL
IFN-y	NULL
(	NULL
y	NULL
;	NULL
5	NULL
ng/	NULL
ml	NULL
for	NULL
15	NULL
min	NULL
;	NULL
Genzyme	NULL
)	NULL
,	NULL
or	NULL
B-1	NULL
cells	NULL
(	NULL
7.5	NULL
X	NULL
10°	NULL
)	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
incubated	NULL
with	NULL
radiolabeled	NULL
oligonucleotide	NULL
containing	NULL
the	NULL
£	NULL
high-affinity	NULL
cfos	NULL
SIE	NULL
sequence	NULL
(	NULL
28	NULL
)	NULL
.	NULL

Arrows	NULL
E	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
STAT	NULL
3	NULL
homodimers	NULL
*	NULL
(	NULL
SIF	NULL
A	NULL
)	NULL
,	NULL
STAT3-STAT1	NULL
heterodimers	NULL
(	NULL
SIF	NULL
B	NULL
)	NULL
,	NULL
and	NULL
STAT1	NULL
homodimers	NULL
(	NULL
SIF	NULL
C	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Specific	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
constitutive	NULL
B-1	NULL
SIE-binding	NULL
complex	NULL
.	NULL

Competition	NULL
analysis	NULL
was	NULL
performed	NULL
on	NULL
nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
B-1	NULL
cells	NULL
in	NULL
an	NULL
EMSA	NULL
using	NULL
20-fold	NULL
excess	NULL
unlabeled	NULL
SIE	NULL
or	NULL
NF-AT	NULL
(	NULL
control	NULL
)	NULL
oli-gonucleotides	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
SIE-binding	NULL
complexes	NULL
containing	NULL
SIF	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C.	NULL
(	NULL
C	NULL
)	NULL
Serum	NULL
does	NULL
not	NULL
induce	NULL
SIF	NULL
A	NULL
in	NULL
B-1	NULL
cells	NULL
SIE-EMSA	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
B-1	NULL
cells	NULL
purified	NULL
and	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
serum-free	NULL
medium	NULL
alone	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
or	NULL
in	NULL
serum-free	NULL
medium	NULL
plus	NULL
IL-6	NULL
(	NULL
1,000	NULL
U/	NULL
ml	NULL
for	NULL
15	NULL
min	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
or	NULL
subsequent	NULL
resuspension	NULL
in	NULL
serum-containing	NULL
RPMI	NULL
medium	NULL
for	NULL
15	NULL
min	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
.	NULL

B-2	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
were	NULL
cultured	NULL
in	NULL
serum-containing	NULL
RPMI	NULL
medium	NULL
alone	NULL
.	NULL

IL-6	NULL
<	NULL
--	NULL
SIF	NULL
A	NULL
<	NULL
-	NULL
SIF	NULL
B	NULL
<	NULL
-sSIF	NULL
C	NULL
phosphotyrosine	NULL
``	NULL
*	NULL
``	NULL
ST	NULL
AT	NULL
3	NULL
.	NULL

The	NULL
mobility	NULL
shift	NULL
assay	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
top	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
either	NULL
unstimulated	NULL
B-	NULL
1	NULL
or	NULL
B-2	NULL
cells	NULL
or	NULL
from	NULL
B-2	NULL
cells	NULL
treated	NULL
with	NULL
IL-6	NULL
for	NULL
15	NULL
min	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
SIE	NULL
oligonucleotide	NULL
before	NULL
EMSA	NULL
.	NULL

The	NULL
SIF	NULL
A	NULL
complexes	NULL
constitutively	NULL
present	NULL
in	NULL
untreated	NULL
B-1	NULL
cells	NULL
and	NULL
IL-6-treated	NULL
B-2	NULL
cells	NULL
were	NULL
found	NULL
to	NULL
contain	NULL
phosphotyrosine	NULL
``	NULL
*	NULL
``	NULL
STAT3	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
immunoblotting	NULL
material	NULL
obtained	NULL
from	NULL
the	NULL
native	NULL
gel	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
B	NULL
,	NULL
bottom	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
AT	NULL
3	NULL
electrophoresed	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
the	NULL
SIE-containing	NULL
oligonucleotide	NULL
(	NULL
no	NULL
DNA	NULL
control	NULL
)	NULL
was	NULL
observed	NULL
to	NULL
migrate	NULL
more	NULL
slowly	NULL
in	NULL
the	NULL
gel	NULL
,	NULL
distinguishing	NULL
it	NULL
from	NULL
SIE-bound	NULL
STAT	NULL
3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
confirm	NULL
that	NULL
STAT3	NULL
is	NULL
constitutively	NULL
present	NULL
in	NULL
B-1	NULL
nuclei	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
su-pershifting	NULL
experiments	NULL
outlined	NULL
above	NULL
and	NULL
show	NULL
that	NULL
it	NULL
is	NULL
present	NULL
as	NULL
a	NULL
tyrosine	NULL
phosphorylated	NULL
protein	NULL
in	NULL
the	NULL
SIF	NULL
A	NULL
complex	NULL
.	NULL

We	NULL
further	NULL
examined	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
STAT3	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
B-1	NULL
and	NULL
B-2	NULL
cells	NULL
CNTF	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
induce	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
two	NULL
STAT3	NULL
isoforms	NULL
,	NULL
p88	NULL
and	NULL
p89	NULL
(	NULL
31	NULL
)	NULL
.	NULL

These	NULL
isoforms	NULL
,	NULL
whose	NULL
phosphorylation	NULL
is	NULL
also	NULL
inducible	NULL
by	NULL
IL-6	NULL
(	NULL
29	NULL
,	NULL
32	NULL
,	NULL
33	NULL
)	NULL
,	NULL
have	NULL
been	NULL
termed	NULL
STAT3	NULL
;	NULL
(	NULL
p88	NULL
)	NULL
,	NULL
for	NULL
faster	NULL
migrating	NULL
and	NULL
STAT	NULL
3	NULL
,	NULL
(	NULL
p89	NULL
)	NULL
,	NULL
for	NULL
slower	NULL
migrating	NULL
(	NULL
32	NULL
,	NULL
34	NULL
)	NULL
.	NULL

Immunoblotting	NULL
with	NULL
antiserum	NULL
specific	NULL
for	NULL
STAT	NULL
3	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
``	NULL
showed	NULL
that	NULL
B-2	NULL
cells	NULL
express	NULL
little	NULL
nuclear	NULL
AT	NULL
3	NULL
,	NULL
or	NULL
STAT	NULL
3	NULL
,	NULL
as	NULL
expected	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
EMSA	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
A	NULL
)	NULL
.	NULL

In	NULL
comparison	NULL
,	NULL
B-1	NULL
cell	NULL
A	NULL
m	NULL
IL-6	NULL
B	NULL
EMSA	NULL
~	NULL
«	NULL
cha	NULL
P918	NULL
Bi	NULL
_B2	NULL
-	NULL
-	NULL
-f	NULL
_-	NULL
_-	NULL
a-ptyrSTAT1	NULL
in	NULL
[	NULL
tel	NULL
|	NULL
|	NULL
&	NULL
'	NULL
tw	NULL
_	NULL
g	NULL
a	NULL
ag	NULL
--	NULL
ct	NULL
gp	NULL
.	NULL

q	NULL
ag	NULL
4	NULL
P9	NULL
C	NULL
B2B1	NULL
M	NULL
B2	NULL
WESTERN	NULL
IL-6	NULL
I	NULL
he	NULL
Tuk	NULL
JDBQ	NULL
|	NULL
ye	NULL
~	NULL
p88	NULL
i	NULL
CREB	NULL
@	NULL
@	NULL
|	NULL
&	NULL
=	NULL
-	NULL
u	NULL
|	NULL
&	NULL
p	NULL
6-1	NULL
Ba	NULL
Mr	NULL
(	NULL
kp	NULL
)	NULL
p	NULL
M	NULL
M	NULL
Y	NULL
--	NULL
J	NULL
91	NULL
97	NULL
pe	NULL
?	NULL

.	NULL

¥	NULL
p	NULL
Figure	NULL
2	NULL
.	NULL

-	NULL
Immunoreactivity	NULL
of	NULL
B-1	NULL
cell	NULL
SIF	NULL
A	NULL
with	NULL
STAT3-specific	NULL
antisera	NULL
,	NULL
and	NULL
detection	NULL
of	NULL
constitutively	NULL
expressed	NULL
B-1	NULL
cell	NULL
STAT	NULL
1	NULL
and	NULL
3	NULL
isoforms	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSA	NULL
supershift/	NULL
immunoinhibition	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
B-1	NULL
cells	NULL
(	NULL
M	NULL
)	NULL
or	NULL
B-2	NULL
cells	NULL
stimulated	NULL
with	NULL
IL-6	NULL
and	NULL
antibody	NULL
to	NULL
the	NULL
NH	NULL
-terminal	NULL
region	NULL
of	NULL
STAT	NULL
1	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
supershift	NULL
STAT3	NULL
activated	NULL
by	NULL
IL-6	NULL
or	NULL
CNTF	NULL
(	NULL
a-p91N	NULL
)	NULL
.	NULL

Antiserum	NULL
specific	NULL
for	NULL
phosphorylated	NULL
STAT	NULL
1	NULL
(	NULL
a-ptyrSTAT1	NULL
)	NULL
(	NULL
26	NULL
)	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
positions	NULL
of	NULL
SIF	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C.	NULL
(	NULL
B	NULL
)	NULL
B-1	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
-	NULL
)	NULL
and	NULL
B-2	NULL
cells	NULL
were	NULL
either	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
IL-6	NULL
(	NULL
1,000	NULL
U/	NULL
ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
,	NULL
after	NULL
which	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Nuclear	NULL
extracted	NULL
protein	NULL
was	NULL
analyzed	NULL
by	NULL
EMSA	NULL
using	NULL
the	NULL
P-labeled	NULL
SIE-containing	NULL
oligonucleotide	NULL
probe	NULL
and	NULL
5	NULL
%	NULL
nondenaturing	NULL
PAGE	NULL
.	NULL

Retarded	NULL
radiolabeled	NULL
oligonucleotide	NULL
was	NULL
separated	NULL
from	NULL
DNA-binding	NULL
proteins	NULL
by	NULL
a	NULL
Shift-Western	NULL
pro-cedure	NULL
,	NULL
using	NULL
electrotransfer	NULL
to	NULL
Whatman	NULL
DE-81	NULL
paper	NULL
and	NULL
nitrocellulose	NULL
filter	NULL
paper	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
SIE-containing	NULL
oligonucleotide	NULL
was	NULL
visualized	NULL
by	NULL
autoradiography	NULL
and	NULL
DNA-binding	NULL
protein	NULL
was	NULL
immunoblotted	NULL
with	NULL
STAT3	NULL
phosphotyrosine	NULL
'	NULL
``	NULL
-specific	NULL
antibody	NULL
and	NULL
detected	NULL
by	NULL
ECL	NULL
(	NULL
bottom	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
the	NULL
specific	NULL
SIE-binding	NULL
nucleoprotein	NULL
complexes	NULL
and	NULL
immunoblotted	NULL
phosphotyrosine	NULL
``	NULL
®STAT3	NULL
are	NULL
indicated	NULL
(	NULL
arrows	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Immunoblot	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
unstimulated	NULL
B-2	NULL
or	NULL
B-	NULL
1	NULL
cells	NULL
(	NULL
@	NULL
?	NULL
)	NULL

or	NULL
B-2	NULL
cells	NULL
that	NULL
were	NULL
incubated	NULL
with	NULL
medium	NULL
alone	NULL
(	NULL
M	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
IL-6	NULL
(	NULL
B-2/IL-6	NULL
;	NULL
1,000	NULL
U/ml	NULL
for	NULL
15	NULL
min	NULL
)	NULL
(	NULL
wight	NULL
)	NULL
,	NULL
probed	NULL
with	NULL
antibody	NULL
specific	NULL
for	NULL
STAT	NULL
3	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
705	NULL
.	NULL

Arrows	NULL
indicate	NULL
fast	NULL
(	NULL
p88	NULL
)	NULL
and	NULL
slow	NULL
(	NULL
p89	NULL
)	NULL
migrating	NULL
forms	NULL
of	NULL
STAT3	NULL
.	NULL

To	NULL
test	NULL
for	NULL
equal	NULL
loading	NULL
of	NULL
lanes	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
reprobed	NULL
with	NULL
an	NULL
antibody	NULL
to	NULL
the	NULL
constitutively	NULL
expressed	NULL
nuclear	NULL
transcription	NULL
factor	NULL
,	NULL
CREB	NULL
(	NULL
UBI	NULL
,	NULL
Lake	NULL
Placid	NULL
,	NULL
NY	NULL
)	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Immunoblot	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
(	NULL
M	NULL
)	NULL
B-1	NULL
or	NULL
B-2	NULL
cells	NULL
(	NULL
lanes	NULL
/	NULL
and	NULL
2	NULL
)	NULL
or	NULL
B-2	NULL
cells	NULL
stimulated	NULL
with	NULL
IFN-y	NULL
(	NULL
5	NULL
ng/ml	NULL
for	NULL
15	NULL
min	NULL
;	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
probed	NULL
with	NULL
antibody	NULL
specific	NULL
for	NULL
phosphotyrosine	NULL
``	NULL
``	NULL
ST	NULL
AT	NULL
1	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Arrows	NULL
indicate	NULL
91-	NULL
and	NULL
84-kD	NULL
isoforms	NULL
of	NULL
STAT	NULL
1	NULL
.	NULL

1038	NULL
nuclear	NULL
extracts	NULL
were	NULL
found	NULL
to	NULL
contain	NULL
roughly	NULL
equal	NULL
levels	NULL
of	NULL
phosphotyrosine	NULL
``	NULL
*	NULL
``	NULL
STAT3	NULL
,	NULL
and	NULL
STAT3	NULL
,	NULL
,	NULL
respectively	NULL
,	NULL
which	NULL
co-migrated	NULL
with	NULL
IL-6-induced	NULL
phosphotyrosine	NULL
``	NULL
STAT3	NULL
from	NULL
B-2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
immunoblotting	NULL
untreated	NULL
B-1	NULL
cell	NULL
nuclear	NULL
extracts	NULL
with	NULL
antibody	NULL
specific	NULL
for	NULL
STAT	NULL
1	NULL
phosphorylated	NULL
on	NULL
tyrosine	NULL
``	NULL
``	NULL
'	NULL
(	NULL
26	NULL
)	NULL
detected	NULL
activated	NULL
STAT	NULL
1	NULL
of	NULL
the	NULL
p91	NULL
isoform	NULL
,	NULL
which	NULL
was	NULL
not	NULL
present	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
untreated	NULL
B-2	NULL
cells	NULL
but	NULL
was	NULL
inducible	NULL
by	NULL
IFN-y	NULL
treatment	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
D	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
B-1-spe-cific	NULL
expression	NULL
of	NULL
SIF	NULL
A	NULL
correlates	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
phosphotyrosine	NULL
``	NULL
forms	NULL
of	NULL
STAT	NULL
3	NULL
,	NULL
and	NULL
STAT	NULL
3	NULL
;	NULL
in	NULL
nuclei	NULL
from	NULL
unstimulated	NULL
B-1	NULL
cells	NULL
,	NULL
and	NULL
B-1	NULL
cells	NULL
also	NULL
constitutively	NULL
express	NULL
a	NULL
small	NULL
amount	NULL
of	NULL
activated	NULL
p91-ST	NULL
AT	NULL
1	NULL
.	NULL

The	NULL
presence	NULL
of	NULL
SIF	NULL
A	NULL
and	NULL
AT	NULL
3	NULL
in	NULL
B-	NULL
1	NULL
cells	NULL
could	NULL
not	NULL
be	NULL
due	NULL
to	NULL
macrophage	NULL
contamination	NULL
,	NULL
because	NULL
purified	NULL
macrophages	NULL
isolated	NULL
by	NULL
adherence	NULL
during	NULL
B	NULL
cell	NULL
purification	NULL
from	NULL
the	NULL
same	NULL
animals	NULL
did	NULL
not	NULL
contain	NULL
nuclear	NULL
SIF	NULL
A	NULL
or	NULL
AT	NULL
3	NULL
,	NULL
and	NULL
histologic	NULL
examination	NULL
of	NULL
B-	NULL
1	NULL
populations	NULL
revealed	NULL
less	NULL
than	NULL
2	NULL
%	NULL
macrophage	NULL
contamination	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
overnight	NULL
incubation	NULL
of	NULL
B-1	NULL
cells	NULL
with	NULL
neutralizing	NULL
antibody	NULL
to	NULL
IL-10	NULL
before	NULL
preparation	NULL
of	NULL
nuclear	NULL
extracts	NULL
did	NULL
not	NULL
result	NULL
in	NULL
diminution	NULL
of	NULL
the	NULL
SIF	NULL
A	NULL
complex	NULL
observed	NULL
by	NULL
EMSA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
an	NULL
IL-10	NULL
autocrine	NULL
loop	NULL
B	NULL
alg	NULL
3h	NULL
5	NULL
£	NULL
-	NULL
o-	NULL
-t-	NULL
a-ptyrSTAT1	NULL
r-	NULL
&	NULL
B	NULL
9	NULL
d	NULL
C	NULL
--	NULL
z	NULL
UUU	NULL
=	NULL
-	NULL
<	NULL
li-	NULL
--	NULL
Figure	NULL
3	NULL
.	NULL

Inducible	NULL
nuclear	NULL
expression	NULL
of	NULL
STAT3	NULL
in	NULL
B-2	NULL
cells	NULL
treated	NULL
with	NULL
anti-Ig	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Delayed	NULL
nuclear	NULL
expression	NULL
of	NULL
SIF	NULL
A	NULL
in	NULL
anti-Ig-stimu-lated	NULL
B-2	NULL
cells	NULL
.	NULL

EMSA	NULL
analysis	NULL
for	NULL
SIE-binding	NULL
activity	NULL
was	NULL
carried	NULL
out	NULL
using	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
B-2	NULL
cells	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
-	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragments	NULL
of	NULL
goat	NULL
anti-mouse	NULL
IgM	NULL
(	NULL
alg	NULL
;	NULL
15	NULL
pg/ml	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

Arrows	NULL
indicate	NULL
positions	NULL
of	NULL
nucleoprotein	NULL
complexes	NULL
containing	NULL
SIF	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C.	NULL
(	NULL
B	NULL
)	NULL
Immunoreactivity	NULL
of	NULL
anti-Ig-induced	NULL
B-2	NULL
cell	NULL
SIF	NULL
A	NULL
with	NULL
a	NULL
STAT3-specific	NULL
antiserum	NULL
.	NULL

Gel	NULL
mobility	NULL
supershift/	NULL
immunoinhibition	NULL
analysis	NULL
was	NULL
performed	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
B-2	NULL
cells	NULL
stimulated	NULL
with	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
GaMIgM	NULL
(	NULL
alg	NULL
)	NULL
for	NULL
3	NULL
h	NULL
and	NULL
added	NULL
to	NULL
radiolabeled	NULL
SIE-containing	NULL
oligonucleotide	NULL
before	NULL
addition	NULL
of	NULL
antiserum	NULL
specific	NULL
for	NULL
STAT3	NULL
(	NULL
«	NULL
-p91N	NULL
)	NULL
or	NULL
for	NULL
phosphorylated	NULL
STAT	NULL
1	NULL
(	NULL
a	NULL
«	NULL
-ptyrST	NULL
AT	NULL
1	NULL
)	NULL
;	NULL
see	NULL
legend	NULL
to	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Arrows	NULL
indicate	NULL
the	NULL
position	NULL
of	NULL
nucleoprotein	NULL
complexes	NULL
containing	NULL
SIF	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C.	NULL
Activated	NULL
STAT3	NULL
in	NULL
B-1	NULL
Cells	NULL
A	NULL
C4	NULL
|	NULL
<	NULL
+	NULL
>	NULL
on	NULL
-	NULL
--	NULL
-	NULL
HA1dO4	NULL
--	NULL
-	NULL
o-	NULL
_	NULL
HA1004	NULL
-	NULL
p89	NULL
l	NULL
34	NULL
£	NULL
~	NULL
p88	NULL
}	NULL
|	NULL
_	NULL
-a-n	NULL
-W	NULL
z	NULL
--	NULL
-*	NULL
~-	NULL
CREB	NULL
C	NULL
M	NULL
alg	NULL
IL-6	NULL
--	NULL
+-+	NULL
CHX	NULL
-	NULL
p89	NULL
~	NULL
p88	NULL
#	NULL
D	NULL
Cd	NULL
S	NULL
$	NULL
+o	NULL
+	NULL
£	NULL
£	NULL
€	NULL
.	NULL

&	NULL
®	NULL
®	NULL
0	NULL
o	NULL
I	NULL
C	NULL
CG	NULL
woe	NULL
ne	NULL
e	NULL
-	NULL
pBg	NULL
'	NULL
~	NULL
p88	NULL
Figure	NULL
4	NULL
.	NULL

Unique	NULL
features	NULL
of	NULL
the	NULL
surface	NULL
Ig-	NULL
mediated	NULL
STAT	NULL
E	NULL
signaling	NULL
pathway	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
Induction	NULL
of	NULL
tyrosine	NULL
phosphory-	NULL
M	NULL
alg	NULL
alg	NULL
alg	NULL
lated	NULL
STAT3	NULL
by	NULL
anti-lg	NULL
in	NULL
B-2	NULL
3h	NULL
3h	NULL
3h	NULL
cells	NULL
requires	NULL
serine/threonine	NULL
VH	NULL
rap	NULL
phosphorylation	NULL
.	NULL

Nuclear	NULL
ex	NULL
tracts	NULL
were	NULL
obtained	NULL
from	NULL
B-2	NULL
cells	NULL
stimulated	NULL
for	NULL
3	NULL
h	NULL
with	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
GaMIgM	NULL
(	NULL
alg	NULL
)	NULL
alone	NULL
or	NULL
with	NULL
alg	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
either	NULL
the	NULL
serine/	NULL
threonine	NULL
kinase	NULL
inhibitor	NULL
H-7	NULL
,	NULL
or	NULL
its	NULL
less	NULL
active	NULL
structural	NULL
analogue	NULL
,	NULL
HAIOO4	NULL
(	NULL
both	NULL
at	NULL
25	NULL
pM	NULL
;	NULL
LC	NULL
Laboratories	NULL
)	NULL
and	NULL
probed	NULL
with	NULL
antibody	NULL
-	NULL
specific	NULL
for	NULL
phos	NULL
photyrosine	NULL
``	NULL
STAT3	NULL
(	NULL
A4	NULL
)	NULL
.	NULL

Arrows	NULL
indicate	NULL
fast	NULL
(	NULL
p88	NULL
)	NULL
and	NULL
slow	NULL
(	NULL
p89	NULL
)	NULL
migrating	NULL
forms	NULL
of	NULL
phosphorylated	NULL
STAT3	NULL
.	NULL

To	NULL
test	NULL
for	NULL
equal	NULL
loading	NULL
of	NULL
lanes	NULL
,	NULL
the	NULL
blot	NULL
was	NULL
reprobed	NULL
with	NULL
an	NULL
antibody	NULL
to	NULL
the	NULL
constitutively	NULL
expressed	NULL
nuclear	NULL
transcription	NULL
factor	NULL
,	NULL
CREB	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
also	NULL
analyzed	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Arrows	NULL
indicate	NULL
positions	NULL
of	NULL
nucleoprotein	NULL
complexes	NULL
containing	NULL
SIF	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C.	NULL
(	NULL
C	NULL
)	NULL
Induction	NULL
of	NULL
STAT	NULL
3	NULL
,	NULL
after	NULL
anti-Ig	NULL
treatment	NULL
is	NULL
blocked	NULL
by	NULL
cycloheximide	NULL
.	NULL

Primary	NULL
B	NULL
cells	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
M	NULL
)	NULL
or	NULL
were	NULL
treated	NULL
with	NULL
IL-6	NULL
(	NULL
1,000	NULL
U/	NULL
ml	NULL
)	NULL
for	NULL
15	NULL
min	NULL
,	NULL
or	NULL
with	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
goat	NULL
anti-mouse	NULL
IgM	NULL
(	NULL
15	NULL
g/	NULL
ml	NULL
;	NULL
alg	NULL
)	NULL
for	NULL
3	NULL
h	NULL
,	NULL
after	NULL
which	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Before	NULL
stimulation	NULL
,	NULL
some	NULL
B	NULL
Wt	NULL
;	NULL
-	NULL
vs	NULL
ts	NULL
bi	NULL
but	NULL
1039	NULL
Karras	NULL
et	NULL
al	NULL
.	NULL

does	NULL
not	NULL
account	NULL
for	NULL
the	NULL
observed	NULL
elevated	NULL
levels	NULL
of	NULL
STAT	NULL
3	NULL
in	NULL
unstimulated	NULL
B-1	NULL
cells	NULL
and	NULL
that	NULL
constitutive	NULL
STAT3	NULL
expression	NULL
is	NULL
intrinsic	NULL
to	NULL
this	NULL
population	NULL
.	NULL

Previous	NULL
work	NULL
has	NULL
shown	NULL
that	NULL
anti-Ig	NULL
treatment	NULL
of	NULL
B-2	NULL
cells	NULL
results	NULL
in	NULL
STAT	NULL
1	NULL
activation	NULL
(	NULL
35	NULL
)	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
B-	NULL
1	NULL
cells	NULL
represent	NULL
a	NULL
population	NULL
of	NULL
conventional	NULL
B	NULL
cells	NULL
previously	NULL
activated	NULL
through	NULL
their	NULL
antigen	NULL
receptors	NULL
.	NULL

For	NULL
these	NULL
reasons	NULL
,	NULL
STAT3	NULL
activation	NULL
was	NULL
evaluated	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
B-2	NULL
cells	NULL
treated	NULL
with	NULL
anti-Ig	NULL
.	NULL

Nuclear	NULL
extracts	NULL
from	NULL
anti-Ig-treated	NULL
B-2	NULL
cells	NULL
formed	NULL
a	NULL
SIF	NULL
A	NULL
complex	NULL
with	NULL
the	NULL
SIE	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
untreated	NULL
B-1	NULL
cells	NULL
,	NULL
although	NULL
this	NULL
activity	NULL
was	NULL
only	NULL
present	NULL
in	NULL
extracts	NULL
from	NULL
cells	NULL
stimulated	NULL
for	NULL
3	NULL
h	NULL
or	NULL
more	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
A	NULL
)	NULL
.	NULL

As	NULL
with	NULL
B-1	NULL
SIF	NULL
A	NULL
,	NULL
anti-p91N	NULL
but	NULL
not	NULL
antiserum	NULL
to	NULL
phosphotyrosine	NULL
``	NULL
``	NULL
``	NULL
ST	NULL
AT	NULL
1	NULL
disrupted	NULL
SIF	NULL
A	NULL
induced	NULL
by	NULL
anti-Ig	NULL
in	NULL
B-2	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
B	NULL
)	NULL
and	NULL
formed	NULL
a	NULL
supershifted	NULL
complex	NULL
with	NULL
SIF	NULL
A	NULL
that	NULL
was	NULL
visible	NULL
in	NULL
longer	NULL
exposures	NULL
and	NULL
co-migrated	NULL
with	NULL
a	NULL
similar	NULL
complex	NULL
recognized	NULL
by	NULL
anti-pI1N	NULL
in	NULL
IL-6-treated	NULL
B	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
phosphotyrosine	NULL
``	NULL
``	NULL
ST	NULL
AT	NULL
3	NULL
,	NULL
was	NULL
detected	NULL
by	NULL
immunoblotting	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
B-2	NULL
cells	NULL
treated	NULL
for	NULL
3	NULL
h	NULL
with	NULL
anti-Ig	NULL
,	NULL
although	NULL
little	NULL
phos-photyrosine	NULL
``	NULL
ST	NULL
AT	NULL
3	NULL
;	NULL
was	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

B	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-Ig	NULL
for	NULL
less	NULL
than	NULL
3	NULL
h	NULL
did	NULL
not	NULL
contain	NULL
nuclear	NULL
AT	NULL
3	NULL
,	NULL
or	NULL
STAT	NULL
3	NULL
,	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
cross-linking	NULL
slg	NULL
in	NULL
B-2	NULL
cells	NULL
generates	NULL
activated	NULL
nuclear	NULL
STAT	NULL
3	NULL
of	NULL
predominantly	NULL
the	NULL
STAT	NULL
3	NULL
,	NULL
isoform	NULL
,	NULL
much	NULL
like	NULL
IL-6	NULL
treatment	NULL
of	NULL
B-2	NULL
cells	NULL
but	NULL
dissimilar	NULL
from	NULL
the	NULL
AT	NULL
3	NULL
profile	NULL
of	NULL
unstimulated	NULL
B-1	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
levels	NULL
of	NULL
STAT	NULL
3	NULL
,	NULL
and	NULL
STAT	NULL
3	NULL
;	NULL
are	NULL
nearly	NULL
equal	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
C	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
constitutively	NULL
expressed	NULL
B-1	NULL
cell	NULL
STAT	NULL
3	NULL
is	NULL
not	NULL
the	NULL
same	NULL
as	NULL
STAT	NULL
3	NULL
induced	NULL
in	NULL
B-2	NULL
cells	NULL
by	NULL
sIg	NULL
or	NULL
cytokine	NULL
receptor	NULL
engagement	NULL
.	NULL

The	NULL
formation	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
cytokine-induced	NULL
STAT3	NULL
complexes	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
require	NULL
inducible	NULL
serine	NULL
phosphorylation	NULL
(	NULL
32	NULL
,	NULL
36	NULL
)	NULL
.	NULL

Because	NULL
many	NULL
slg	NULL
triggered	NULL
downstream	NULL
events	NULL
are	NULL
PKC	NULL
dependent	NULL
,	NULL
we	NULL
tested	NULL
whether	NULL
anti-Ig	NULL
induction	NULL
of	NULL
STAT3	NULL
in	NULL
B-2	NULL
cells	NULL
is	NULL
sensitive	NULL
to	NULL
inhibition	NULL
of	NULL
serine/	NULL
threonine	NULL
phosphorylation	NULL
,	NULL
using	NULL
the	NULL
inhibitor	NULL
,	NULL
H7	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
phosphotyrosine	NULL
``	NULL
``	NULL
ST	NULL
AT	NULL
3	NULL
,	NULL
by	NULL
anti-Ig	NULL
was	NULL
completely	NULL
inhibited	NULL
by	NULL
H7	NULL
but	NULL
not	NULL
by	NULL
treatment	NULL
with	NULL
(	NULL
the	NULL
control	NULL
analog	NULL
)	NULL
HA1OO4	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
A	NULL
)	NULL
.	NULL

Preincubation	NULL
with	NULL
H7	NULL
but	NULL
not	NULL
with	NULL
HA1004	NULL
cell	NULL
cultures	NULL
were	NULL
pretreated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
CHX	NULL
(	NULL
10	NULL
g/	NULL
ml	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

Nuclear	NULL
extracted	NULL
protein	NULL
was	NULL
size	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
7.5	NULL
%	NULL
gels	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
phosphotyrosine	NULL
``	NULL
``	NULL
STAT3-specific	NULL
antibody	NULL
,	NULL
detected	NULL
by	NULL
ECL	NULL
.	NULL

Arrows	NULL
indicate	NULL
fast	NULL
(	NULL
p88	NULL
)	NULL
and	NULL
slow	NULL
(	NULL
p89	NULL
)	NULL
migrating	NULL
forms	NULL
of	NULL
phosphorylated	NULL
STAT	NULL
3	NULL
.	NULL

(	NULL
D	NULL
and	NULL
E	NULL
)	NULL
Rapamycin	NULL
inhibits	NULL
anti-Ig-induced	NULL
activation	NULL
of	NULL
STAT	NULL
3	NULL
.	NULL

Primary	NULL
B	NULL
cells	NULL
(	NULL
1.5	NULL
X	NULL
10	NULL
``	NULL
)	NULL
were	NULL
incubated	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
-	NULL
)	NULL
or	NULL
were	NULL
stimulated	NULL
with	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
goat	NULL
anti-mouse	NULL
IgM	NULL
(	NULL
15	NULL
g/	NULL
ml	NULL
;	NULL
alg	NULL
)	NULL
for	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
after	NULL
which	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

Before	NULL
stimulation	NULL
,	NULL
some	NULL
B	NULL
cell	NULL
cultures	NULL
were	NULL
pretreated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
either	NULL
rapamycin	NULL
at	NULL
20	NULL
ng/	NULL
ml	NULL
(	NULL
rapa	NULL
)	NULL
or	NULL
ethanol	NULL
(	NULL
vehicle	NULL
,	NULL
VH	NULL
)	NULL
.	NULL

Nuclear	NULL
extracted	NULL
protein	NULL
was	NULL
size	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
on	NULL
7.5	NULL
%	NULL
gels	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
phos	NULL
photyrosine	NULL
``	NULL
ST	NULL
AT	NULL
3-specific	NULL
antibody	NULL
,	NULL
detected	NULL
by	NULL
ECL	NULL
(	NULL
D	NULL
)	NULL
.	NULL

The	NULL
positions	NULL
of	NULL
molecular	NULL
size	NULL
markers	NULL
and	NULL
phospho-ST	NULL
AT	NULL
3	NULL
(	NULL
wrrow	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
also	NULL
analyzed	NULL
by	NULL
EMSA	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
(	NULL
F	NULL
)	NULL
.	NULL

Arrows	NULL
indicate	NULL
positions	NULL
of	NULL
nucleoprotein	NULL
complexes	NULL
containing	NULL
SIF	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C.	NULL
also	NULL
completely	NULL
blocked	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
SIF	NULL
A-binding	NULL
complex	NULL
in	NULL
EMSA	NULL
experiments	NULL
conducted	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
B-2	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-Ig	NULL
for	NULL
3	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
B	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
nuclear	NULL
localization	NULL
of	NULL
3	NULL
,	NULL
and	NULL
the	NULL
appearance	NULL
of	NULL
nuclear	NULL
SIF	NULL
A	NULL
in	NULL
B-2	NULL
cells	NULL
stimulated	NULL
by	NULL
anti-Ig	NULL
requires	NULL
serine/	NULL
threonine	NULL
phosphorylation	NULL
and	NULL
further	NULL
implicate	NULL
STAT	NULL
3	NULL
,	NULL
in	NULL
the	NULL
composition	NULL
of	NULL
the	NULL
anti-Ig-induced	NULL
SIF	NULL
A	NULL
complex	NULL
.	NULL

The	NULL
delayed	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
after	NULL
slg	NULL
ligation	NULL
in	NULL
B-2	NULL
cells	NULL
suggested	NULL
that	NULL
the	NULL
synthesis	NULL
of	NULL
an	NULL
intermediary	NULL
protein	NULL
is	NULL
required	NULL
for	NULL
this	NULL
response	NULL
.	NULL

To	NULL
test	NULL
this	NULL
possibility	NULL
,	NULL
B-2	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
anti-Ig	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
protein	NULL
synthesis	NULL
inhibitor	NULL
cycloheximide	NULL
(	NULL
CHX	NULL
)	NULL
and	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
.	NULL

CHX	NULL
completely	NULL
blocked	NULL
the	NULL
induction	NULL
of	NULL
phosphotyrosine	NULL
``	NULL
``	NULL
ST	NULL
AT	NULL
3	NULL
,	NULL
in	NULL
nuclear	NULL
extracts	NULL
from	NULL
B-2	NULL
cells	NULL
treated	NULL
with	NULL
anti-Ig	NULL
for	NULL
3	NULL
h	NULL
,	NULL
whereas	NULL
CHX	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
AT	NULL
3	NULL
stimulated	NULL
by	NULL
IL-6	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
C	NULL
)	NULL
.	NULL

CHX	NULL
also	NULL
abrogated	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
SIF	NULL
A-binding	NULL
complex	NULL
in	NULL
EMSA	NULL
experiments	NULL
performed	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
B-2	NULL
cells	NULL
stimulated	NULL
with	NULL
anti-Ig	NULL
for	NULL
3	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
both	NULL
SIF	NULL
A	NULL
and	NULL
of	NULL
phosphotyrosine	NULL
``	NULL
``	NULL
ST	NULL
AT	NULL
3	NULL
,	NULL
by	NULL
anti-	NULL
Ig	NULL
.	NULL

Since	NULL
anti-Ig	NULL
is	NULL
a	NULL
mitogenic	NULL
stimulus	NULL
for	NULL
B-2	NULL
cells	NULL
,	NULL
we	NULL
reasoned	NULL
that	NULL
induction	NULL
of	NULL
STAT3	NULL
via	NULL
this	NULL
novel	NULL
mechanism	NULL
may	NULL
be	NULL
sensitive	NULL
to	NULL
immunosuppressive	NULL
drugs	NULL
that	NULL
inhibit	NULL
B	NULL
cell	NULL
proliferation	NULL
,	NULL
such	NULL
as	NULL
cyclosporin	NULL
A	NULL
,	NULL
FK506	NULL
,	NULL
and	NULL
rapamycin	NULL
(	NULL
37	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Immunoblot	NULL
analysis	NULL
of	NULL
nuclear	NULL
extracted	NULL
protein	NULL
showed	NULL
substantial	NULL
inhibition	NULL
of	NULL
anti-Ig-induced	NULL
phosphotyrosine	NULL
``	NULL
*	NULL
``	NULL
ST	NULL
AT	NULL
3	NULL
,	NULL
by	NULL
rapamycin	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
D	NULL
)	NULL
.	NULL

Rapamycin	NULL
also	NULL
significantly	NULL
blocked	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
anti-Ig-inducible	NULL
SIF	NULL
A	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
£	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
of	NULL
rapamycin	NULL
is	NULL
specific	NULL
for	NULL
slg-triggered	NULL
STAT3	NULL
because	NULL
induction	NULL
of	NULL
3	NULL
by	NULL
IL-6	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
rapamycin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
B-2	NULL
cell	NULL
treatment	NULL
with	NULL
CsA	NULL
had	NULL
a	NULL
minimal	NULL
effect	NULL
on	NULL
nuclear	NULL
expression	NULL
of	NULL
AT	NULL
3	NULL
,	NULL
after	NULL
anti-Ig	NULL
stimulation	NULL
but	NULL
completely	NULL
inhibited	NULL
nuclear	NULL
phosphotyrosine	NULL
``	NULL
``	NULL
ST	NULL
AT	NULL
3	NULL
,	NULL
induced	NULL
by	NULL
the	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
the	NULL
calcium	NULL
ionophore	NULL
,	NULL
ionomycin	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
demonstrating	NULL
an	NULL
additional	NULL
level	NULL
of	NULL
specificity	NULL
for	NULL
the	NULL
effect	NULL
of	NULL
rapamycin	NULL
on	NULL
anti-Ig-induced	NULL
STAT	NULL
3	NULL
.	NULL

Both	NULL
the	NULL
delayed	NULL
appearance	NULL
and	NULL
dependence	NULL
on	NULL
protein	NULL
synthesis	NULL
of	NULL
in	NULL
B-2	NULL
cells	NULL
after	NULL
anti-Ig	NULL
stimulation	NULL
raised	NULL
the	NULL
possibility	NULL
that	NULL
sig-mediated	NULL
STAT3	NULL
induction	NULL
may	NULL
be	NULL
due	NULL
to	NULL
the	NULL
release	NULL
of	NULL
cytokines	NULL
from	NULL
the	NULL
B	NULL
cells	NULL
themselves	NULL
or	NULL
from	NULL
other	NULL
contaminating	NULL
cells	NULL
in	NULL
the	NULL
B-2	NULL
cell	NULL
preparation	NULL
after	NULL
treatment	NULL
with	NULL
anti-Ig	NULL
.	NULL

To	NULL
address	NULL
this	NULL
question	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
the	NULL
mature	NULL
B	NULL
cell	NULL
line	NULL
BAL-17	NULL
were	NULL
prepared	NULL
and	NULL
immunoblotted	NULL
for	NULL
phosphotyrosine	NULL
``	NULL
®ST	NULL
AT	NULL
3	NULL
after	NULL
stimulation	NULL
with	NULL
anti-Ig	NULL
.	NULL

AT	NULL
3	NULL
,	NULL
was	NULL
induced	NULL
in	NULL
BAL-17	NULL
B	NULL
cells	NULL
by	NULL
anti-Ig	NULL
treatment	NULL
with	NULL
similar	NULL
kinetics	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
B-2	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
ruling	NULL
out	NULL
a	NULL
role	NULL
for	NULL
a	NULL
factor	NULL
secreted	NULL
by	NULL
a	NULL
contaminating	NULL
non-B	NULL
cell	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
culture	NULL
supernatants	NULL
from	NULL
B	NULL
cells	NULL
stimulated	NULL
by	NULL
anti-Ig	NULL
for	NULL
3	NULL
h	NULL
were	NULL
transfered	NULL
to	NULL
naive	NULL
cells	NULL
,	NULL
from	NULL
which	NULL
nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
after	NULL
15	NULL
min	NULL
and	NULL
tested	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
1040	NULL
B-2	NULL
B-1	NULL
E	NULL
i	NULL
w	NULL
<	NULL
5	NULL
9	NULL
a	NULL
-	NULL
2	NULL
+o	NULL
+	NULL
©	NULL
-	NULL
G	NULL
©	NULL
_	NULL
m	NULL
in	NULL
in	NULL
in	NULL
w	NULL
of	NULL
ojo	NULL
T	NULL
|m99¢9	NULL
©	NULL
®	NULL
6	NULL
=-u	NULL
‘	NULL
,	NULL
-1—	NULL
E	NULL
u	NULL
-	NULL
<	NULL
g-wat	NULL
Figure	NULL
5	NULL
.	NULL

Failure	NULL
of	NULL
prolonged	NULL
anti-Ig	NULL
treatment	NULL
of	NULL
B-2	NULL
cells	NULL
to	NULL
reproduce	NULL
the	NULL
B-1	NULL
cell	NULL
nuclear	NULL
STAT3	NULL
profile	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
untreated	NULL
B-1	NULL
cells	NULL
and	NULL
from	NULL
B-2	NULL
cells	NULL
incubated	NULL
with	NULL
either	NULL
medium	NULL
alone	NULL
(	NULL
-	NULL
)	NULL
,	NULL
or	NULL
treated	NULL
with	NULL
IL-6	NULL
for	NULL
15	NULL
min	NULL
;	NULL
nuclear	NULL
extracts	NULL
were	NULL
also	NULL
prepared	NULL
from	NULL
B-2	NULL
cells	NULL
treated	NULL
with	NULL
anti-Ig	NULL
(	NULL
2.5	NULL
g/m	NULL
!	NULL
)	NULL

for	NULL
2.5	NULL
d	NULL
or	NULL
2.5	NULL
d	NULL
anti-Ig-treated	NULL
B-2	NULL
cells	NULL
subsequently	NULL
stimulated	NULL
with	NULL
ci-ther	NULL
PMA	NULL
for	NULL
1	NULL
h	NULL
or	NULL
IL-6	NULL
for	NULL
15	NULL
min	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Arrows	NULL
indicate	NULL
positions	NULL
of	NULL
nucleoprotein	NULL
complexes	NULL
containing	NULL
SIF	NULL
A	NULL
,	NULL
B	NULL
,	NULL
and	NULL
C.	NULL
by	NULL
immunoblotting	NULL
.	NULL

Supernatants	NULL
from	NULL
cultures	NULL
treated	NULL
with	NULL
anti-Ig	NULL
for	NULL
3	NULL
h	NULL
did	NULL
not	NULL
induce	NULL
appreciable	NULL
rapid	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
3	NULL
in	NULL
previously	NULL
naive	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
as	NULL
would	NULL
be	NULL
expected	NULL
of	NULL
a	NULL
cytokine-mediated	NULL
response	NULL
.	NULL

These	NULL
results	NULL
,	NULL
coupled	NULL
with	NULL
the	NULL
sensitivity	NULL
of	NULL
this	NULL
response	NULL
to	NULL
rapamycin	NULL
,	NULL
which	NULL
does	NULL
not	NULL
inhibit	NULL
cytokine-mediated	NULL
STAT	NULL
signaling	NULL
,	NULL
suggest	NULL
that	NULL
the	NULL
delayed	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT	NULL
3	NULL
is	NULL
specific	NULL
to	NULL
anti-Ig	NULL
treatment	NULL
and	NULL
is	NULL
not	NULL
the	NULL
result	NULL
of	NULL
cytokine	NULL
release	NULL
or	NULL
synthesis	NULL
triggered	NULL
by	NULL
cell	NULL
activation	NULL
.	NULL

Prolonged	NULL
exposure	NULL
of	NULL
B-2	NULL
cells	NULL
to	NULL
anti-Ig	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
for	NULL
2.5	NULL
d	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
result	NULL
in	NULL
the	NULL
acquisition	NULL
of	NULL
surface	NULL
CD5	NULL
expression	NULL
and	NULL
proliferative	NULL
responsiveness	NULL
to	NULL
PMA	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
.	NULL

The	NULL
possibility	NULL
that	NULL
prolonged	NULL
slg	NULL
crosslinking	NULL
produces	NULL
a	NULL
B-1-like	NULL
basal	NULL
level	NULL
of	NULL
nuclear	NULL
activated	NULL
STAT3	NULL
was	NULL
tested	NULL
by	NULL
treating	NULL
B-2	NULL
cells	NULL
with	NULL
anti-Ig	NULL
for	NULL
several	NULL
days	NULL
before	NULL
nuclear	NULL
extraction	NULL
.	NULL

Although	NULL
B-2	NULL
cells	NULL
treated	NULL
with	NULL
anti-Ig	NULL
for	NULL
2.5	NULL
d	NULL
responded	NULL
to	NULL
PMA	NULL
by	NULL
cell	NULL
cycle	NULL
progression	NULL
to	NULL
S	NULL
phase	NULL
,	NULL
sig-	NULL
mediated	NULL
nuclear	NULL
SIF	NULL
A	NULL
(	NULL
which	NULL
was	NULL
apparent	NULL
at	NULL
3	NULL
h	NULL
)	NULL
had	NULL
disappeared	NULL
by	NULL
this	NULL
time	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

This	NULL
result	NULL
indicates	NULL
that	NULL
STAT	NULL
3	NULL
induced	NULL
by	NULL
anti-Ig	NULL
in	NULL
B-2	NULL
cells	NULL
is	NULL
only	NULL
transiently	NULL
expressed	NULL
,	NULL
and	NULL
thus	NULL
long	NULL
term	NULL
T	NULL
cell-inde-pendent	NULL
type	NULL
II	NULL
(	NULL
TT-2	NULL
)	NULL
antigenic	NULL
stimulation	NULL
of	NULL
B-2	NULL
cells	NULL
does	NULL
not	NULL
recapitulate	NULL
the	NULL
profile	NULL
of	NULL
activated	NULL
STAT	NULL
3	NULL
characteris	NULL
tic	NULL
of	NULL
B-1	NULL
cells	NULL
,	NULL
despite	NULL
inducing	NULL
other	NULL
B-1-like	NULL
changes	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
activated	NULL
STAT	NULL
3	NULL
expression	NULL
is	NULL
an	NULL
intrinsic	NULL
and	NULL
unique	NULL
characteristic	NULL
of	NULL
B-	NULL
1	NULL
cells	NULL
.	NULL

Activated	NULL
STAT3	NULL
in	NULL
B-1	NULL
Cells	NULL
In	NULL
conclusion	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
constitutive	NULL
nuclear	NULL
activated	NULL
STAT	NULL
3	NULL
in	NULL
normal	NULL
murine	NULL
B-	NULL
1	NULL
lymphocytes	NULL
,	NULL
representing	NULL
the	NULL
first	NULL
nuclear	NULL
transcriptional	NULL
identifier	NULL
for	NULL
this	NULL
developmentally	NULL
regulated	NULL
B	NULL
cell	NULL
population	NULL
.	NULL

The	NULL
B-1	NULL
cell	NULL
subset	NULL
has	NULL
been	NULL
linked	NULL
to	NULL
spontaneously	NULL
arising	NULL
B	NULL
cell	NULL
tumors	NULL
,	NULL
and	NULL
STAT3	NULL
has	NULL
been	NULL
found	NULL
to	NULL
be	NULL
activated	NULL
in	NULL
v-ab/-trans	NULL
formed	NULL
B	NULL
cells	NULL
HTLV-I-transformed	NULL
T	NULL
cells	NULL
,	NULL
and	NULL
v-se	NULL
transformed	NULL
fibroblasts	NULL
(	NULL
17-20	NULL
)	NULL
.	NULL

Basal	NULL
levels	NULL
of	NULL
nuclear	NULL
phosphorylated	NULL
STAT	NULL
3	NULL
may	NULL
reflect	NULL
,	NULL
or	NULL
may	NULL
cause	NULL
,	NULL
the	NULL
activated	NULL
state	NULL
of	NULL
B-	NULL
1	NULL
cells	NULL
,	NULL
and	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
self-renewing	NULL
growth	NULL
characteristics	NULL
and	NULL
the	NULL
oncogenic	NULL
potential	NULL
of	NULL
normal	NULL
B-1	NULL
cells	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
both	NULL
ege1	NULL
and	NULL
c-myc	NULL
mR	NULL
N	NULL
A	NULL
levels	NULL
do	NULL
not	NULL
differ	NULL
between	NULL
B-1	NULL
and	NULL
B-2	NULL
cells	NULL
(	NULL
41	NULL
)	NULL
.	NULL

There	NULL
has	NULL
been	NULL
considerable	NULL
debate	NULL
over	NULL
whether	NULL
B-1	NULL
cells	NULL
are	NULL
derived	NULL
from	NULL
a	NULL
separate	NULL
lineage	NULL
of	NULL
progenitor	NULL
cells	NULL
or	NULL
represent	NULL
B-2	NULL
cells	NULL
that	NULL
have	NULL
undergone	NULL
internal	NULL
biochemical	NULL
and	NULL
external	NULL
cell	NULL
surface	NULL
marker	NULL
changes	NULL
due	NULL
to	NULL
prior	NULL
activational	NULL
or	NULL
differentiative	NULL
responses	NULL
,	NULL
such	NULL
as	NULL
those	NULL
delivered	NULL
by	NULL
TI-2	NULL
antigens	NULL
(	NULL
42	NULL
,	NULL
43	NULL
)	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
one	NULL
activity	NULL
of	NULL
slg	NULL
cross-linking	NULL
in	NULL
conventional	NULL
B	NULL
cells	NULL
is	NULL
to	NULL
activate	NULL
STAT	NULL
3	NULL
,	NULL
which	NULL
occurs	NULL
in	NULL
delayed	NULL
fashion	NULL
,	NULL
involves	NULL
phosphorylation	NULL
of	NULL
tyrosine	NULL
``	NULL
,	NULL
and	NULL
is	NULL
dependent	NULL
upon	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
,	NULL
serine/threonine	NULL
phosphorylation	NULL
,	NULL
and	NULL
the	NULL
participation	NULL
of	NULL
a	NULL
rapamycin-inhibitable	NULL
kinase	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
is	NULL
coupled	NULL
to	NULL
nuclear	NULL
expression	NULL
of	NULL
activated	NULL
STAT	NULL
proteins	NULL
(	NULL
this	NULL
work	NULL
and	NULL
references	NULL
16	NULL
,	NULL
35	NULL
)	NULL
.	NULL

Notably	NULL
,	NULL
many	NULL
features	NULL
of	NULL
this	NULL
coupling	NULL
stand	NULL
in	NULL
stark	NULL
contrast	NULL
to	NULL
the	NULL
accepted	NULL
paradigm	NULL
for	NULL
STAT	NULL
activation	NULL
mediated	NULL
by	NULL
cytokine	NULL
receptors	NULL
,	NULL
in	NULL
which	NULL
STAT	NULL
phosphorylation	NULL
occurs	NULL
rapidly	NULL
,	NULL
does	NULL
not	NULL
require	NULL
protein	NULL
synthesis	NULL
,	NULL
and	NULL
is	NULL
independent	NULL
of	NULL
rapamycin-sensitive	NULL
kinase	NULL
activity	NULL
.	NULL

However	NULL
,	NULL
the	NULL
basal	NULL
presence	NULL
of	NULL
both	NULL
activated	NULL
STAT	NULL
3	NULL
,	NULL
and	NULL
STAT	NULL
3	NULL
;	NULL
in	NULL
unstimulated	NULL
B-	NULL
1	NULL
cells	NULL
contrasts	NULL
with	NULL
the	NULL
transient	NULL
induction	NULL
of	NULL
predominantly	NULL
the	NULL
STAT	NULL
3	NULL
,	NULL
iso-form	NULL
in	NULL
anti-Ig	NULL
stimulated	NULL
B-2	NULL
cells	NULL
and	NULL
suggests	NULL
that	NULL
cross	NULL
linking	NULL
slg	NULL
alone	NULL
does	NULL
not	NULL
result	NULL
in	NULL
similar	NULL
nuclear	NULL
expression	NULL
,	NULL
in	NULL
B-2	NULL
cells	NULL
,	NULL
of	NULL
this	NULL
activated	NULL
transcription	NULL
factor	NULL
present	NULL
in	NULL
B-1	NULL
cells	NULL
Therefore	NULL
,	NULL
constitutive	NULL
B-1	NULL
cell	NULL
STAT3	NULL
expression	NULL
suggests	NULL
that	NULL
the	NULL
development	NULL
of	NULL
these	NULL
B	NULL
cells	NULL
can	NULL
not	NULL
be	NULL
explained	NULL
by	NULL
TI-2	NULL
antigen-mediated	NULL
influences	NULL
alone	NULL
,	NULL
and	NULL
that	NULL
STAT	NULL
proteins	NULL
play	NULL
a	NULL
role	NULL
in	NULL
directing	NULL
the	NULL
unique	NULL
behavioral	NULL
and	NULL
phenotypic	NULL
characteristics	NULL
of	NULL
this	NULL
population	NULL
of	NULL
normal	NULL
cells	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
C.	NULL
Schindler	NULL
for	NULL
his	NULL
gift	NULL
of	NULL
anti-p91N	NULL
antibody	NULL
and	NULL
D.	NULL
Francis	NULL
for	NULL
valuable	NULL
input	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
United	NULL
States	NULL
Public	NULL
Health	NULL
Service	NULL
Grant	NULL
AI29690	NULL
to	NULL
TL	NULL
.	NULL

Rothstein	NULL
.	NULL

Address	NULL
correspondence	NULL
to	NULL
Thomas	NULL
L.	NULL
Rothstein	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Evans-556	NULL
,	NULL
Boston	NULL
Medical	NULL
Center	NULL
,	NULL
88	NULL
East	NULL
Newton	NULL
St.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02118	NULL
.	NULL

Received	NULL
for	NULL
publication	NULL
7	NULL
O	NULL
ober	NULL
1996	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
13	NULL
January	NULL
1997	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Kantor	NULL
,	NULL
A.B	NULL
.	NULL

,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1993	NULL
.	NULL

Origin	NULL
of	NULL
murine	NULL
B	NULL
cell	NULL
lineages	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11:501-538	NULL
.	NULL

2	NULL
.	NULL

Hayakawa	NULL
,	NULL
K.	NULL
,	NULL
R.R	NULL
.	NULL

Hardy	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1986	NULL
.	NULL

Peritoneal	NULL
Ly-1	NULL
B	NULL
cells	NULL
:	NULL
genetic	NULL
control	NULL
,	NULL
autoantibody	NULL
pro-duction	NULL
,	NULL
increased	NULL
lambda	NULL
light	NULL
chain	NULL
expression	NULL
.	NULL

Eur	NULL
:	NULL
J	NULL
Immunol	NULL
.	NULL

16:450-456	NULL
.	NULL

3	NULL
.	NULL

Sherr	NULL
,	NULL
D.H.	NULL
,	NULL
and	NULL
ME	NULL
.	NULL

Dorf	NULL
.	NULL

1984	NULL
.	NULL

An	NULL
idiotype-specific	NULL
helper	NULL
population	NULL
that	NULL
bears	NULL
immunoglobulin	NULL
,	NULL
Ia	NULL
,	NULL
and	NULL
Lyt-1	NULL
determinants	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

159:1189-1200	NULL
.	NULL

4	NULL
.	NULL

Hardin	NULL
,	NULL
J.A	NULL
.	NULL

,	NULL
K.	NULL
Vos	NULL
,	NULL
Y.	NULL
Kawano	NULL
,	NULL
and	NULL
D.H.	NULL
Sherr	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
function	NULL
for	NULL
Ly-1*	NULL
B	NULL
cells	NULL
Proc	NULL
Soc	NULL
Exp	NULL
.	NULL

Biol	NULL
.	NULL

Med	NULL
.	NULL

195	NULL
:	NULL
172-182	NULL
.	NULL

5	NULL
.	NULL

Caligaris	NULL
Cappio	NULL
,	NULL
F.	NULL
,	NULL
M.	NULL
Gobbi	NULL
,	NULL
M.	NULL
Bofill	NULL
,	NULL
and	NULL
G.	NULL
Janossy	NULL
.	NULL

1982	NULL
.	NULL

Infrequent	NULL
normal	NULL
B	NULL
lymphocytes	NULL
express	NULL
features	NULL
of	NULL
B-chronic	NULL
lymphocytic	NULL
leukemia	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

155:623-632	NULL
.	NULL

6	NULL
.	NULL

Burastero	NULL
,	NULL
SE	NULL
.	NULL

,	NULL
P.	NULL
Casali	NULL
,	NULL
R	NULL
.L	NULL
.	NULL

Wilder	NULL
,	NULL
and	NULL
A.L	NULL
.	NULL

Notkins	NULL
.	NULL

1988	NULL
.	NULL

Monoreactive	NULL
high	NULL
affinity	NULL
and	NULL
polyreactive	NULL
low	NULL
affinity	NULL
rtheum-atoid	NULL
factors	NULL
are	NULL
produced	NULL
by	NULL
CDS*	NULL
B	NULL
cells	NULL
from	NULL
patients	NULL
with	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

168:1979-1992	NULL
.	NULL

7	NULL
.	NULL

Sidman	NULL
,	NULL
C.L	NULL
.	NULL

,	NULL
LD	NULL
.	NULL

Shultz	NULL
,	NULL
R.R	NULL
.	NULL

Hardy	NULL
,	NULL
K.	NULL
Hayakawa	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1986	NULL
.	NULL

Production	NULL
of	NULL
immunoglobulin	NULL
iso-types	NULL
by	NULL
Ly-1*	NULL
B	NULL
cells	NULL
in	NULL
viable	NULL
motheaten	NULL
and	NULL
normal	NULL
mice	NULL
.	NULL

Sdence	NULL
(	NULL
W	NULL
ash	NULL
.	NULL

DC	NULL
)	NULL
.	NULL

232:1423-1425	NULL
.	NULL

8	NULL
.	NULL

Kroese	NULL
,	NULL
F.G.M	NULL
.	NULL

,	NULL
E.C	NULL
.	NULL

Butcher	NULL
,	NULL
A.M	NULL
.	NULL

Stall	NULL
,	NULL
P.A	NULL
.	NULL

Lalor	NULL
,	NULL
S.	NULL
Ad	NULL
1041	NULL
Karras	NULL
et	NULL
al	NULL
.	NULL

ams	NULL
,	NULL
and	NULL
L.A.	NULL
Herzenberg	NULL
.	NULL

1989	NULL
.	NULL

Many	NULL
of	NULL
the	NULL
IgA	NULL
producing	NULL
plasma	NULL
cells	NULL
in	NULL
murine	NULL
gut	NULL
are	NULL
derived	NULL
from	NULL
self-replenishing	NULL
precursors	NULL
in	NULL
the	NULL
peritoneal	NULL
cavity	NULL
.	NULL

Intl	NULL
.	NULL

Immunol	NULL
.	NULL

1:75-84	NULL
.	NULL

9	NULL
.	NULL

Braun	NULL
,	NULL
J.	NULL
,	NULL
Y.	NULL
Citri	NULL
,	NULL
D.	NULL
Baltimore	NULL
,	NULL
F.	NULL
Forouzanpour	NULL
,	NULL
L.	NULL
King	NULL
,	NULL
K.	NULL
Teheranizadeh	NULL
,	NULL
M.	NULL
Bray	NULL
,	NULL
and	NULL
S.	NULL
Kliewer	NULL
.	NULL

1986	NULL
.	NULL

B-Lyl1	NULL
cells	NULL
:	NULL
immortal	NULL
Ly-1+*	NULL
B	NULL
lymphocyte	NULL
cell	NULL
lines	NULL
spontaneously	NULL
arising	NULL
in	NULL
murine	NULL
splenic	NULL
cultures	NULL
.	NULL

Immunol	NULL
.	NULL

Rev	NULL
.	NULL

93:5-28	NULL
.	NULL

10	NULL
.	NULL

Rothstein	NULL
,	NULL
TL	NULL
.	NULL

,	NULL
and	NULL
D.L	NULL
.	NULL

Kolber	NULL
.	NULL

1988	NULL
.	NULL

Peritoneal	NULL
B	NULL
cells	NULL
respond	NULL
to	NULL
phorbol	NULL
esters	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
co-mitogen	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

140:2880-2885	NULL
.	NULL

11	NULL
.	NULL

Rothstein	NULL
,	NULL
TL	NULL
.	NULL

,	NULL
and	NULL
D.L	NULL
.	NULL

Kolber	NULL
.	NULL

1988	NULL
.	NULL

Anti-Ig	NULL
antibody	NULL
inhibits	NULL
the	NULL
phorbol	NULL
ester-induced	NULL
stimulation	NULL
of	NULL
peritoneal	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

141:4089-4093	NULL
.	NULL

12	NULL
.	NULL

Darnell	NULL
,	NULL
J.E	NULL
.	NULL

,	NULL
Jr.	NULL
,	NULL
LM	NULL
.	NULL

Kerr	NULL
,	NULL
and	NULL
G.M	NULL
.	NULL

Stark	NULL
.	NULL

1994	NULL
.	NULL

Jak-ST	NULL
AT	NULL
pathways	NULL
and	NULL
transcriptional	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
IFN	NULL
s	NULL
and	NULL
other	NULL
extracellular	NULL
signaling	NULL
proteins	NULL
.	NULL

S	NULL
@	NULL
ene	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

264:1415-1421	NULL
.	NULL

13	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
J.E	NULL
.	NULL

Darnell	NULL
,	NULL
Jr.	NULL
1995	NULL
.	NULL

Transcriptional	NULL
responses	NULL
to	NULL
polypeptide	NULL
ligands	NULL
:	NULL
the	NULL
JAK-STAT	NULL
pathway	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

64:621-651	NULL
.	NULL

14	NULL
.	NULL

Thle	NULL
,	NULL
J.N	NULL
.	NULL

1995	NULL
.	NULL

Cytokine	NULL
receptor	NULL
signaling	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

.	NULL

377:591-594	NULL
.	NULL

15	NULL
.	NULL

Shuai	NULL
,	NULL
K.	NULL
,	NULL
C.M	NULL
.	NULL

Horvarth	NULL
,	NULL
LH	NULL
.	NULL

Tsai-Huang	NULL
,	NULL
S.A.	NULL
Quereshi	NULL
,	NULL
D.	NULL
Cowburn	NULL
,	NULL
and	NULL
J.E	NULL
.	NULL

Darnell	NULL
,	NULL
Jr.	NULL
1994	NULL
.	NULL

Interferon	NULL
activation	NULL
16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29.	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
stat91	NULL
involves	NULL
dimerization	NULL
through	NULL
SH2-phosphotyrosyl	NULL
peptide	NULL
interactions	NULL
.	NULL

Cell	NULL
.	NULL

76:821-828	NULL
.	NULL

Karras	NULL
,	NULL
J.G	NULL
.	NULL

,	NULL
Z.	NULL
Wang	NULL
,	NULL
S.J	NULL
.	NULL

Coniglio	NULL
,	NULL
D.A	NULL
.	NULL

Frank	NULL
,	NULL
and	NULL
TL	NULL
.	NULL

Rothstein	NULL
.	NULL

1996	NULL
.	NULL

Antigen	NULL
receptor	NULL
engagement	NULL
in	NULL
B	NULL
cells	NULL
induces	NULL
nuclear	NULL
expression	NULL
of	NULL
STAT	NULL
S5	NULL
and	NULL
STAT	NULL
6	NULL
proteins	NULL
that	NULL
bind	NULL
and	NULL
transactivate	NULL
an	NULL
IFN-y	NULL
activation	NULL
site	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

157:39-47	NULL
.	NULL

Migone	NULL
,	NULL
T-S.	NULL
,	NULL
JX	NULL
.	NULL

Lin	NULL
,	NULL
A.	NULL
Cereseto	NULL
,	NULL
J.C.	NULL
Mulloy	NULL
,	NULL
JJ	NULL
.	NULL

O'Shea	NULL
,	NULL
G.	NULL
Franchini	NULL
,	NULL
and	NULL
W.J	NULL
.	NULL

Leonard	NULL
.	NULL

1995	NULL
.	NULL

Constitutively	NULL
activated	NULL
Jak-STAT	NULL
pathway	NULL
in	NULL
T	NULL
cells	NULL
transformed	NULL
with	NULL
HTLV-I	NULL
.	NULL

Saene	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

269:79-81	NULL
.	NULL

Yu	NULL
,	NULL
C-L.	NULL
,	NULL
D.J	NULL
.	NULL

Meyer	NULL
,	NULL
G.S	NULL
.	NULL

Campbell	NULL
,	NULL
A.C.	NULL
Larner	NULL
,	NULL
C.	NULL
Carter-Su	NULL
,	NULL
J.	NULL
Schwartz	NULL
,	NULL
and	NULL
R.	NULL
Jove	NULL
.	NULL

1995	NULL
.	NULL

Enhanced	NULL
DNA-binding	NULL
activity	NULL
of	NULL
a	NULL
Stat3-related	NULL
protein	NULL
in	NULL
cells	NULL
transformed	NULL
by	NULL
the	NULL
Src	NULL
oncoprotein	NULL
.	NULL

Sdene	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

269:81-83	NULL
.	NULL

Hilbert	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
T.-S.	NULL
Migone	NULL
,	NULL
M.	NULL
Kopf	NULL
,	NULL
W	NULL
..J.	NULL
Leonard	NULL
,	NULL
and	NULL
S.	NULL
R	NULL
udikoff	NULL
.	NULL

1996	NULL
.	NULL

Distinct	NULL
tumorigenic	NULL
potential	NULL
of	NULL
abl	NULL
and	NULL
rf	NULL
in	NULL
B	NULL
cell	NULL
neoplasia	NULL
:	NULL
abl	NULL
activates	NULL
the	NULL
IL-6	NULL
signaling	NULL
pathway	NULL
.	NULL

Immunity	NULL
.	NULL

5:81-89	NULL
.	NULL

Cao	NULL
,	NULL
X.	NULL
,	NULL
A.	NULL
Tay	NULL
,	NULL
G.R	NULL
.	NULL

Guy	NULL
,	NULL
and	NULL
Y.H	NULL
.	NULL

Tan	NULL
.	NULL

1996	NULL
.	NULL

Activation	NULL
and	NULL
association	NULL
of	NULL
ST	NULL
AT3	NULL
with	NULL
Sre	NULL
in	NULL
v-Src-transformed	NULL
cell	NULL
lines	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:1595-1603	NULL
.	NULL

Morris	NULL
,	NULL
D.L	NULL
.	NULL

,	NULL
and	NULL
TL	NULL
.	NULL

Rothstein	NULL
.	NULL

1993	NULL
.	NULL

Abnormal	NULL
transcription	NULL
factor	NULL
induction	NULL
through	NULL
the	NULL
surface	NULL
immunoglobulin	NULL
M	NULL
receptor	NULL
of	NULL
B-	NULL
1	NULL
lymphocytes	NULL
.	NULL

J	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

177:857-861	NULL
.	NULL

Liu	NULL
,	NULL
J.	NULL
,	NULL
T.C	NULL
.	NULL

Chiles	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
and	NULL
TL	NULL
.	NULL

Rothstein	NULL
.	NULL

1991	NULL
.	NULL

Inducible	NULL
nuclear	NULL
expression	NULL
of	NULL
NF-KB	NULL
in	NULL
primary	NULL
B	NULL
cells	NULL
stimulated	NULL
through	NULL
the	NULL
surface	NULL
Ig	NULL
receptor	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

146:1685-1691	NULL
.	NULL

Bradford	NULL
,	NULL
M.M	NULL
.	NULL

1976	NULL
.	NULL

A	NULL
rapid	NULL
and	NULL
sensitive	NULL
method	NULL
for	NULL
the	NULL
quantification	NULL
of	NULL
microgram	NULL
quantities	NULL
of	NULL
protein	NULL
utilizing	NULL
the	NULL
principle	NULL
of	NULL
protein-dye	NULL
binding	NULL
.	NULL

Anal	NULL
.	NULL

Biochem	NULL
.	NULL

72:248-257	NULL
.	NULL

Sadowski	NULL
,	NULL
H.B	NULL
.	NULL

,	NULL
K.	NULL
Shuai	NULL
,	NULL
J.E	NULL
.	NULL

Darnell	NULL
,	NULL
Jr.	NULL
,	NULL
and	NULL
M.Z	NULL
.	NULL

Gilman	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
common	NULL
nuclear	NULL
signal	NULL
transduction	NULL
pathway	NULL
activated	NULL
by	NULL
growth	NULL
factor	NULL
and	NULL
cytokine	NULL
receptors	NULL
.	NULL

Sdence	NULL
(	NULL
W	NULL
ash	NULL
.	NULL

DC	NULL
)	NULL
.	NULL

261:1739-1744	NULL
.	NULL

Francis	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
J.G	NULL
.	NULL

Karras	NULL
,	NULL
X.	NULL
Ke	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
and	NULL
TL	NULL
.	NULL

Rothstein	NULL
.	NULL

1995	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
and	NULL
NF-AT	NULL
during	NULL
B	NULL
cell	NULL
stimulation	NULL
through	NULL
the	NULL
CD40	NULL
receptor	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

7:151-161	NULL
.	NULL

Frank	NULL
,	NULL
D.A	NULL
.	NULL

,	NULL
M.J.	NULL
Robertson	NULL
,	NULL
A.	NULL
Bonni	NULL
,	NULL
J.	NULL
Ritz	NULL
,	NULL
and	NULL
M.E	NULL
.	NULL

Greenberg	NULL
.	NULL

1995	NULL
.	NULL

Interleukin	NULL
2	NULL
signaling	NULL
involves	NULL
the	NULL
phos	NULL
phorylation	NULL
of	NULL
Stat	NULL
proteins	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aarid	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

92	NULL
;	NULL
7779-7783	NULL
.	NULL

Wagner	NULL
,	NULL
B.J	NULL
.	NULL

,	NULL
TE	NULL
.	NULL

Hayes	NULL
,	NULL
C.J	NULL
.	NULL

Hoban	NULL
,	NULL
and	NULL
B.H	NULL
.	NULL

Cochran	NULL
.	NULL

1990	NULL
.	NULL

The	NULL
SIF	NULL
binding	NULL
element	NULL
confers	NULL
siy	NULL
PDGF	NULL
inducibil-ity	NULL
onto	NULL
the	NULL
efos	NULL
promoter	NULL
.	NULL

EMBO	NULL
(	NULL
Eur	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

Organ	NULL
.	NULL
)	NULL

J	NULL
.	NULL

9:4477-4484	NULL
.	NULL

R	NULL
uff-Jamison	NULL
,	NULL
S.	NULL
,	NULL
K.	NULL
Chen	NULL
,	NULL
and	NULL
S.	NULL
Cohen	NULL
.	NULL

1993	NULL
.	NULL

Induction	NULL
by	NULL
EGF	NULL
and	NULL
interferon-y	NULL
of	NULL
tyrosine-phosphorylated	NULL
DNA	NULL
binding	NULL
proteins	NULL
in	NULL
mouse	NULL
liver	NULL
nuclei	NULL
.	NULL

Saene	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

261:1733-1736	NULL
.	NULL

Zhong	NULL
,	NULL
Z.	NULL
,	NULL
Z.	NULL
Wen	NULL
,	NULL
and	NULL
J.E	NULL
.	NULL

Darnell	NULL
,	NULL
Jr.	NULL
1994	NULL
.	NULL

Stat3	NULL
and	NULL
Stat4	NULL
:	NULL
members	NULL
of	NULL
the	NULL
family	NULL
of	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
.	NULL

Proc	NULL
Natl	NULL
.	NULL

Aar	NULL
.	NULL

Sa	NULL
.	NULL

USA	NULL
.	NULL

91:4806-4810	NULL
.	NULL

1042	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

Activated	NULL
STAT3	NULL
in	NULL
B-1	NULL
Cells	NULL
Rothman	NULL
,	NULL
P.	NULL
,	NULL
B.	NULL
Kreider	NULL
,	NULL
M.	NULL
Azam	NULL
,	NULL
D.	NULL
Levy	NULL
,	NULL
U.	NULL
Wegenka	NULL
,	NULL
A.	NULL
Eilers	NULL
,	NULL
T.	NULL
Decker	NULL
,	NULL
F.	NULL
Horn	NULL
,	NULL
H.	NULL
Kashleva	NULL
,	NULL
J.	NULL
Ihle	NULL
,	NULL
and	NULL
C.	NULL
Schindler	NULL
.	NULL

1994	NULL
.	NULL

Cytokines	NULL
and	NULL
growth	NULL
factors	NULL
signal	NULL
through	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
family	NULL
of	NULL
related	NULL
transcription	NULL
factors	NULL
.	NULL

Immunity	NULL
.	NULL

1:457-468	NULL
.	NULL

Bonni	NULL
,	NULL
A.	NULL
,	NULL
D.A	NULL
.	NULL

Frank	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
and	NULL
M.E	NULL
.	NULL

Greenberg	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
pathway	NULL
for	NULL
ciliary	NULL
neurotrophic	NULL
factor	NULL
signaling	NULL
to	NULL
the	NULL
nucleus	NULL
Sdere	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

262	NULL
:	NULL
1575-1579	NULL
.	NULL

Zhang	NULL
,	NULL
X.	NULL
,	NULL
J.	NULL
Blenis	NULL
,	NULL
H-C	NULL
Li	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
and	NULL
S.	NULL
Chen-Kiang	NULL
.	NULL

1995	NULL
.	NULL

R	NULL
equirement	NULL
of	NULL
serine	NULL
phosphorylation	NULL
for	NULL
formation	NULL
of	NULL
STAT-promoter	NULL
complexes	NULL
.	NULL

Sdene	NULL
(	NULL
Wash.	NULL
DC	NULL
)	NULL
.	NULL

267:1990-1994	NULL
.	NULL

Akira	NULL
,	NULL
S.	NULL
,	NULL
Y.	NULL
Nishio	NULL
,	NULL
M.	NULL
Inoue	NULL
,	NULL
X.-J	NULL
.	NULL

Wang	NULL
,	NULL
S.	NULL
Wei	NULL
,	NULL
T.	NULL
Mat-susaka	NULL
,	NULL
K.	NULL
Yoshida	NULL
,	NULL
T.	NULL
Sudo	NULL
,	NULL
M.	NULL
Naruto	NULL
,	NULL
and	NULL
T.	NULL
Kishimoto	NULL
.	NULL

1994	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
APRF	NULL
,	NULL
a	NULL
novel	NULL
IFN	NULL
-stimulated	NULL
gene	NULL
factor	NULL
3	NULL
p91-related	NULL
transcription	NULL
factor	NULL
involved	NULL
in	NULL
the	NULL
gp130-mediated	NULL
signaling	NULL
pathway	NULL
.	NULL

Cell	NULL
.	NULL

77:63-71	NULL
.	NULL

Wegenka	NULL
,	NULL
U.M	NULL
.	NULL

,	NULL
C.	NULL
Lutticken	NULL
,	NULL
J.	NULL
Buschmann	NULL
,	NULL
J.	NULL
Yuan	NULL
,	NULL
F.	NULL
Lottspeich	NULL
,	NULL
W.	NULL
Muller-Esterl	NULL
,	NULL
C.	NULL
Schindler	NULL
,	NULL
E.	NULL
Roeb	NULL
,	NULL
P.C	NULL
.	NULL

Heinrich	NULL
,	NULL
and	NULL
F.	NULL
Horn	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
interleukin-6-activated	NULL
acute-phase	NULL
response	NULL
factor	NULL
is	NULL
antigenically	NULL
and	NULL
functionally	NULL
related	NULL
to	NULL
members	NULL
of	NULL
the	NULL
signal	NULL
transducer	NULL
and	NULL
activator	NULL
of	NULL
transcription	NULL
(	NULL
ST	NULL
AT	NULL
)	NULL
family	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:3186-3196	NULL
.	NULL

Karras	NULL
,	NULL
J.G	NULL
.	NULL

,	NULL
L.	NULL
Huo	NULL
,	NULL
Z.	NULL
Wang	NULL
,	NULL
D.A	NULL
.	NULL

Frank	NULL
,	NULL
J.M	NULL
.	NULL

Zimmet	NULL
,	NULL
and	NULL
TL	NULL
.	NULL

Rothstein	NULL
.	NULL

1996	NULL
.	NULL

Delayed	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
nuclear	NULL
expression	NULL
of	NULL
STAT	NULL
1	NULL
following	NULL
antigen	NULL
receptor	NULL
stimulation	NULL
of	NULL
B	NULL
lymphocytes	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

157:2299-2308	NULL
.	NULL

Wen	NULL
,	NULL
Z.	NULL
,	NULL
Z.	NULL
Zhong	NULL
,	NULL
and	NULL
J.E	NULL
.	NULL

Darnell	NULL
,	NULL
Jr.	NULL
1995	NULL
.	NULL

Maximal	NULL
activation	NULL
of	NULL
transcription	NULL
by	NULL
Statl	NULL
and	NULL
Stat3	NULL
requires	NULL
both	NULL
tyrosine	NULL
and	NULL
serine	NULL
phosphorylation	NULL
.	NULL

Cell	NULL
.	NULL

82:241-250	NULL
.	NULL

Wicker	NULL
,	NULL
LS	NULL
.	NULL

,	NULL
R.C	NULL
.	NULL

Boltz	NULL
,	NULL
V.	NULL
Matt	NULL
,	NULL
E.A	NULL
.	NULL

Nichols	NULL
,	NULL
LB	NULL
.	NULL

Peter-son	NULL
,	NULL
and	NULL
N.H.	NULL
Sigal	NULL
.	NULL

1990	NULL
.	NULL

Suppression	NULL
of	NULL
B	NULL
cell	NULL
activation	NULL
by	NULL
cyclosporin	NULL
A	NULL
,	NULL
FK506	NULL
and	NULL
rapamycin	NULL
.	NULL

Eur	NULL
J	NULL
Immunol	NULL
.	NULL

20	NULL
:	NULL
2277-2283	NULL
.	NULL

Kunz	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
M.N	NULL
.	NULL

Hall	NULL
.	NULL

1993	NULL
.	NULL

Cyclosporin	NULL
A	NULL
,	NULL
FK506	NULL
and	NULL
rapamycin	NULL
:	NULL
more	NULL
than	NULL
just	NULL
immunosuppression	NULL
.	NULL

Trends	NULL
Biochem	NULL
.	NULL

Sa	NULL
.	NULL

18:334-338	NULL
.	NULL

Ying-zi	NULL
,	NULL
C.	NULL
,	NULL
E.	NULL
Rabin	NULL
,	NULL
and	NULL
H.H	NULL
.	NULL

Wortis	NULL
.	NULL

1991	NULL
.	NULL

Treatment	NULL
of	NULL
murine	NULL
CD5~	NULL
B	NULL
cells	NULL
with	NULL
anti-Ig	NULL
,	NULL
but	NULL
not	NULL
LPS	NULL
,	NULL
induces	NULL
surface	NULL
CD5	NULL
:	NULL
two	NULL
B	NULL
cell	NULL
activation	NULL
pathways	NULL
.	NULL

Intl	NULL
.	NULL

Immunol	NULL
.	NULL

3	NULL
:	NULL
467-476	NULL
.	NULL

Rothstein	NULL
,	NULL
TL	NULL
.	NULL

,	NULL
D.L	NULL
.	NULL

Kolber	NULL
,	NULL
TP	NULL
.	NULL

Murphy	NULL
,	NULL
and	NULL
D.P	NULL
.	NULL

Cohen	NULL
.	NULL

1991	NULL
.	NULL

Induction	NULL
of	NULL
phorbol	NULL
ester	NULL
responsiveness	NULL
in	NULL
conventional	NULL
B	NULL
cells	NULL
after	NULL
activation	NULL
via	NULL
surface	NULL
Ig	NULL
.	NULL

J	NULL
Immunol	NULL
.	NULL

147:3728-3735	NULL
.	NULL

Wang	NULL
,	NULL
Z.	NULL
,	NULL
D.L	NULL
.	NULL

Morris	NULL
,	NULL
and	NULL
TL	NULL
.	NULL

Rothstein	NULL
.	NULL

1995	NULL
.	NULL

Constitutive	NULL
and	NULL
inducible	NULL
levels	NULL
of	NULL
ege	NULL
and	NULL
emyc	NULL
early	NULL
growth	NULL
response	NULL
gene	NULL
expression	NULL
in	NULL
B-1	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

162:309-314	NULL
.	NULL

Herzenberg	NULL
,	NULL
L.A.	NULL
,	NULL
and	NULL
A.B	NULL
.	NULL

Kantor	NULL
.	NULL

1993	NULL
.	NULL

B	NULL
cell	NULL
lineages	NULL
exist	NULL
in	NULL
the	NULL
mouse	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

14:79-83	NULL
.	NULL

Haughton	NULL
,	NULL
G.	NULL
,	NULL
LW	NULL
.	NULL

Arnold	NULL
,	NULL
A.C.	NULL
Whitmore	NULL
,	NULL
and	NULL
SH	NULL
.	NULL

Clarke	NULL
.	NULL

1993	NULL
.	NULL

B-1	NULL
cells	NULL
are	NULL
made	NULL
,	NULL
not	NULL
born	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
.	NULL

14:84-87	NULL
.	NULL

